



GENE EXPRESSION ANALYSIS IN MEASLES VIRUS RESEARCH 
 
by  







A dissertation submitted to Johns Hopkins University in conformity  








 The sequencing of the human genome ushered in the era of high-throughput 
biology.  Rapid, whole cell analysis is replacing the molecular reductionist approach of 
the last century.  Microarrays are one of the main high-throughput technologies in this 
field, allowing researchers to query the whole transcriptome of the cell in one 
experiment.  Learning to harness the power of this technology is a significant research 
problem that requires expertise in biology, statistics and computation.  Towards that goal, 
this work examines three projects exploring the role of microarray analysis in biological 
research: an in vitro infection model, acute disease in humans and vaccination in mice. 
 To test the technology in a highly controlled system, an in vitro infection model 
was developed where monocyte-derived dendritic cells were infected with measles virus 
and RNA was extracted over 24 hours.  There were 1553 significantly regulated genes 
during this time, with nearly 60% of them down regulated.  The results were compared to 
other in vitro infection systems, which highlighted a group of genes that formed a core 
response to all the pathogens, including 2’5’ oligoadenylate synthetase, Mx and 
interferon response factors 1 and 7.  The analysis also showed that measles virus is the 
only pathogen that does not induce dsRNA-dependent protein kinase above its 
constitutive expression level.  Measles also induced a robust interferon-α response in 
contrast to the other pathogens.  These results showed that microarray analysis could 
provide a modular view of the immune response. 
 Since microarrays worked well in vitro, they were tested in vivo on peripheral 
blood mononuclear cells from children with acute measles.  We found 13 up regulated 
genes and 206 down regulated genes in children at discharge from the hospital and at 1-
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month follow-up.  All of the up regulated genes peaked at discharge but did not return to 
baseline by the time of follow-up.  The same pattern was found in the down regulated 
genes.  A number of immune factors were up regulated including interleukin-1β, 
interleukin-8, TNF-α, CXCL2 and CCL4.  The down regulated genes were involved in 
three main biological processes: transcription, signal transduction and the immune 
response, but also included the chemokine receptors CCR2 and CCR7.   
 Finally, a vaccine model in mice compared a formalin-inactivated measles 
vaccine (FIMV) with an alphavirus replicon particle vaccine expressing the H protein 
(VCR-H) from measles virus.  Although both vaccines induced comparable antibody 
titers to measles virus, VCR-H induced many more interferon-γ producing cells.  Gene 
expression analysis found many genes significantly regulated at day 4 post-vaccination in 
CD8+ T cells from VCR-H vaccinated mice, while FIMV vaccinated mice did not show 
any gene regulation until day 28.  Many of the genes regulated by both vaccines were 
involved in transcription and signal transduction. 
 High-throughput techniques are changing the nature of biological research by 
providing a new view of the cell.  This increased data load requires more computational 
power and statistical expertise to effectively manage the information and extract 
knowledge.  As scientists learn to harness the power of these new technologies, basic 
understanding of the cell and the fight against disease will benefit.
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Morbillivirus-Host Cell Interactions 
 
 




The Morbillivirus Genus 
 The morbillivirus genus of negative-stranded, enveloped, RNA viruses causes 
severe and often fatal disease in a wide variety of mammals, with neurovirulence and 
immunosuppression salient characteristics.  The genus is found within the 
paramyxoviridae family, which is divided into two subfamilies, the paramyxovirinae and 
the pneumovirinae.  The paramyxovirinae subfamily, in addition to morbilliviruses, also 
includes respiroviruses and rubulaviruses.  Until recently, there were four known 
morbillivirus members:  measles virus (MV), an acute disease of young children, 
rinderpest virus (RPV), which afflicts cattle and artiodactyls, peste des petits ruminants 
virus (PPRV), a disease of small ruminants like goats and sheep, and canine distemper 
virus (CDV), a neurological disorder affecting domestic and wild canines.   
In the late 1980’s, a large number of harbor seals (Phoca vitulina) were 
succumbing to an infectious disease in the seas northwest of Europe.  Initially a team of 
scientists isolated a herpes-virus and a picorna-like virus from the dead seals, but later 
concluded these were opportunistic infections1.  It had been observed that the seals 
exhibited distemper-like symptoms, leading scientists to search for evidence of canine 
distemper virus.  They found that the seal serum reacted to CDV, CDV-like antigens 
could be detected in the lungs, and dogs could be experimentally infected with a virus 
cultured from the seal tissue1, 2, 3.  The virus was eventually isolated and named phocine 
distemper virus4.  Serological studies showed that PDV was more closely related to CDV 
than to MV or RPV5.   
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In 1990, a similar epidemic hit striped dolphins (Stenella coerruleoalba) in the 
western Mediterranean Sea, leading to the identification of dolphin morbillivirus (DMV) 
6.  The epidemic continued to spread, and the next year striped dolphins were also found 
dying in Italy and Greece7.  An analysis of other marine mammals revealed one more 
morbillivirus, porpoise morbillivirus (PMV), which was closely related to DMV8, 9.  
Many other marine mammals have been screened for morbilliviruses, but only serological 
evidence of DMV-like infections in Fin whales (Balaenoptera physalus) has been 
reported10.  Experimentally, DMV and PMV could infect goats, sheep and cows, causing 
viremia and leukopenia11.  Sequence comparisons have shown the DMV is almost 
equidistant from the other known morbilliviruses, suggesting that it may be most closely 
related to the ancestral virus12.       
These marine viruses have caused massive epizootics, killing 18,000 harbor seals 
in 1988 and hundreds of dolphins in the Mediterranean in 19906, 13.  Following the 
outbreaks, the viruses did not seem to be circulating in the wild populations where the 
epidemics occurred, and therefore may have been transmitted from other aquatic or 
terrestrial species14.  Morbilliviruses are spread via respiratory droplets and are some of 
the most contagious pathogens known, so interspecies transmission may frequently 
occur14, 15.  Hooded and ringed seals, which live in the Antarctic, are known to be 
seropositive for PDV and it is believed that DMV may be spread by bottlenose dolphins, 
which can be found throughout the world15.  How and where these carriers transmitted 
the virus to susceptible populations is unknown.  Recently, the finding of a number of 
stranded seals suggests another outbreak is beginning in 200213.  The disease is able to 
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spread rapidly due to the migratory nature of harbor seals, raising concerns about the 
possibility of another epidemic.    
The terrestrial viruses also cause significant morbidity and mortality, particularly 
in Africa, the Middle East, and Asia.  Rinderpest virus primarily infects cattle, causing 
major epidemics in developing countries.  The RPV strains can readily be grouped into 
clades depending on the region of origin16.  Small ruminants succumb to peste des petits 
ruminants virus, which quickly kills young animals17.  There is some overlap in the host 
ranges of RPV and PPRV17.  Finally, measles virus is one of the great human scourges. 
Despite being controlled in much of the world, it still takes an enormous toll on children 
in developing nations.    
  This chapter will examine the molecular interactions between the morbilliviruses 
and the host cell as a prelude to the study examining the host response to the virus in 
Chapter 2.  It will begin with receptor binding and follow viral infection through fusion, 
replication, and finally budding.  The next section will cover the known molecular 
aspects of immunosuppression, a hallmark feature of morbilliviruses and a principal 
cause of the high mortality associated with infection.  Finally, the main issues in 
microarray analysis will be discussed. 
 
The Cellular Receptor 
 Identifying the measles virus receptor has been a long and twisted experimental 
journey.  In 1993, Doris and colleagues used human-rodent somatic cell hybrids to test 
the ability of measles virus to bind to the non-permissive rodent cells18.  They found that 
only those cells containing human chromosome 1 were able to bind virus.  
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Concomitantly, another group in France used a monoclonal antibody that blocked viral 
infection to isolate 57 and 67 kDa proteins19.  Amino-terminal sequencing identified the 
protein as CD46, a complement regulatory protein found on nearly all cells.  Alternative 
splicing and variations in glycosylation lead to 4 different isoforms of the protein19, 20.  
Both groups then expressed CD46 in non-permissive cell lines and were able to show that 
measles virus could bind to the cells and produce infectious virus.  Radioactive labeling 
proved that new virus was being synthesized.  Not all cell lines tested could support viral 
replication though, suggesting other host components may be involved19.  These initial 
studies were conducted with laboratory-adapted strains, and soon it became clear that 
CD46 was not the only molecule involved. 
 CD46 is expressed on most nucleated human cells.  This expression pattern does 
not correlate well with the known tropism of measles virus, which prefers cells of the 
immune system for infection, but can also infect epithelial and neuronal cells.  In 
addition, it was found that wild-type isolates did not grow on cell lines, such as vero 
cells, known to express CD46.  Laboratory and vaccine strains were able to grow on 
these cell lines, but wild-type isolates could only be maintained on primary cells or 
B95a’s, a marmoset B cell line.  CD46 is down regulated following infection with 
vaccine or laboratory strains, but that this did not occur with wild-type strains21.  Data 
such as this convinced several groups that there was more to the MV receptor story. 
 Again, two separate research groups were able to identify another receptor at 
nearly the same time.  Knowing that B cell lines, including B95a cells, were able to 
support wild-type virus replication, a Japanese team lead by Y. Yanagi reasoned that 
these cells contained the receptor coding mRNA.  They transformed the human kidney 
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cell line 293T’s, which can be infected with Edmonston but not wild-type strains of MV, 
with cDNA from B95a cells.  The cells were infected with a VSV construct that replaced 
the VSV G gene with green-fluorescent protein and contained the MV haemagglutinin 
from the KA wild-type strain and the fusion protein from the Edmonston strain.  
Transformed cells that could support MV binding and entry were identified by 
fluorescence.  The group enriched the fluorescent cells until they obtained a single clone 
and then sequenced the B95a cDNA.  The DNA insert was 91% identical to the human 
signaling lymphocyte activation molecule (SLAM), which is also known as CD15022.   
 To confirm the findings, the group first transfected Chinese hamster ovary cells 
with human SLAM.  Then they tested a number of VSV constructs and MV isolates for 
the ability to infect the transfected cells.  Wild-type MV could infect the SLAM 
expressing cells, but not CD46 expressing cells, while the Edmonston strain could infect 
either cell line.  Infectious virus was recovered from these cells at 36 hours22.  In 
addition, the wild-type strains induced cytopathic effect (CPE) on the SLAM expressing 
cells, but not untransfected or CD46-transfected cell lines.  A monoclonal antibody 
against SLAM, IPO-3, blocked wild-type infection and subsequent CPE.  Raji, Ramos, 
BJAB-B95-8, MT-2, and C91/PL are all cell lines known to be susceptible to clinical 
isolates of MV and immunofluorescence showed they all expressed SLAM on their 
surface22.  The non-permissive cell lines, BJAB, Daudi, Jurkat, and MOLT-4 did not22.  
Finally, the group tested 6 clinical isolates and found that they all could infect SLAM-
expressing CHO cells, induce CPE, and the infection could be blocked with IPO-322.       
Expanding on this work, the group also analyzed receptor usage by other 
members of the Morbillivirus genus23.  They cloned the canine and bovine homologs of 
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SLAM and transfected CHO cells with them.  Wild-type isolates of canine distemper 
virus and rinderpest virus could infect the transfected cells but not untransfected controls.  
In addition, the viruses could infect cells expressing SLAM from other species.  Again, 
the wild-type isolates caused CPE in transfected cells and infection was blocked by anti-
SLAM antibody23.   
 Erlenhoefer et al. confirmed SLAM as a MV receptor using an alternative 
approach.  They raised antibodies against the surface proteins of B95a cells and selected 
one that blocked infection with a wild-type strain.  In a separate experiment, they also 
biotinylated B95a cells and incubated them with MV overnight.  Then they precipitated 
the virus-receptor complexes with an antibody directed against MV H.  Running the 
precipitates on an SDS-gel, they concluded that the proteins pulled down by the two 
antibodies were the same size.  To determine the identity of the protein, they used the 
antibody to screen CHO cells transduced with a human splenocyte library.  With this 
technique they independently identified SLAM as a measles virus receptor24.  They also 
found that SLAM was down-regulated from the surface of PBMC's, B95a, and BJAB 
cells following MV infection, leading them to speculate that receptor-binding may play a 
role in MV-induced immunesuppression24.      
 SLAM, a 70-kDA membrane glycoprotein, is a member of the CD2 subset of the 
immunoglobulin superfamily and is found on immature thymocytes, T cells, memory T 
cells, some B cells and mature DCs24, 25, 26.  The cellular expression of SLAM correlates 
better with the known tropism of MV than the ubiquitous CD46.  SLAM is its own ligand 
and is rapidly induced on T cells, B cells, monocytes, and DC's following activation25, 26, 
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27.  SLAM promotes T cell proliferation and IFN-γ production through a CD28-
independent pathway and may help to promote the cell-mediated immune response28.       
As its name implies, SLAM is involved in lymphocyte signaling, particularly in 
bi-directional activation between B and T cells, leading several groups to speculate that 
MV-induced immune suppression may in part be mediated by SLAM engagement22, 24, 29.  
In fact, X-linked lymphoproliferative disease (XLP) and some misdiagnosed cases of 
hemophagocytic lymphohistiocytosis result from defects in SLAM signaling25, 30.  Upon 
CD3 signaling, SLAM colocalizes with the T cell receptor where it is phosphorylated by 
the Src-like kinases Lck or Fyn31.  It then binds with SAP/SH2D1A, the defective gene in 
XLP29.  Activation of the SLAM signaling pathway redirects Th2 responses to a Th1 
profile and induces interferon-γ production.    
 Further studies have supported the finding that SLAM is the receptor for wild-
type measles virus.  The Yanagi group followed up their receptor identification paper 
with an analysis of 9 clinical MV isolates.  Seven of the nine isolates could infect vero 
cells transfected with SLAM cDNA, but none of the isolates could infect untransfected 
vero cells32.  In a similar study, Erlenhoefer et al. used Chinese hamster ovary cells 
expressing CD46 or SLAM to test 28 viral strains for binding and replication.  They 
found that all of the strains tested could infect the SLAM-expressing cells, but only the 
laboratory, vaccine, and a few of the wild-type strains could infect the CD46-expressing 
cells33.  They went on to show that a single amino acid change at position 481, from an 
Asn to a Tyr, of the haemagglutinin (H) protein was sufficient to confer CD46 binding to 
a strain33.  Binding to SLAM was not affected by the mutation.  The MV H protein is a 
type II transmembrane glycoprotein that is important for viral tropism34.  It is responsible 
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for the receptor binding and haemagglutinating properties of the virus, and unlike many 
other paramyxoviruses, the H protein of measles does not possess neuraminidase activity.  
The protein has not been crystallized, but sequence alignments with MV H, influenza N, 
and parainfluenza HN predicted a structure with a globular head sitting atop a stem and 
transmembrane domains35.  The globular head is made of six antiparallel β-pleated 
sheets, which fold to form a superbarrel structure34.  On the cell and virion surface 
disulfide-linked homodimers of H form tetramers36.   
 The MV receptor story may not be finished.  Although the evidence strongly 
supports the use of SLAM by wild-type viruses during natural infection, it still does not 
explain how the virus enters SLAM-negative cells such as epithelial, endothelial, and 
neuronal cells37.  A recent report showed that the virus could enter SLAM-negative cells 
and replicate, but 2 to 3 logs less efficiently than infection of SLAM-positive cells37.  
Continued efforts at understanding receptor usage and viral entry will help to clarify the 
natural course of infection.       
 
Viral Attachment and Fusion 
 Measles virus is a negative-stranded virus that acquires its viral envelope from the 
host plasma membrane.  The matrix (M) protein lines the inner layer of the envelope 
while the haemagglutinin (H) and fusion (F) proteins are exposed on the outside of the 
virus particle.  Their appearance has been described as that of spikes protruding from the 
surface.  To gain entry into a host cell, these proteins must interact with the host plasma 
membrane (PM), fuse the viral envelope to the PM, and deliver the viral genome and 
proteins into the cytoplasm.  The F protein mediates this pH-independent process. 
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 The type I transmembrane F protein is 550 amino acids long and has a molecular 
weight of 60 kDa36, 38.  It was shown in Sendai virus that this protein contains the 
hemolysis, cell fusion, and infection activities of the virus39.  However, the protein is 
synthesized as an inactive precursor protein40.  The F protein is proteolytically activated 
in the Golgi or trans-Golgi network41.  The enzyme responsible for cleaving F into its 
disulfide-linked polypeptides, F1 and F2, is believed to be furin, a subtilisin-like 
protease42.  Following cleavage and activation in the trans-Golgi, F1-F2 is transported to 
the cell surface where it is found as a trimer and may or may not associate with the H 
protein36.  
Paramyxovirus F amino acid sequence comparisons reveal very little homology, 
except at the F1 amino terminus along with nine conserved cysteines38.  Cysteines at 
amino acids 506, 518, and 524 are palmitoylated while those at 506 and 519 were found 
to be particularly crucial for the fusion process43.  All of the fusion proteins examined had 
an overall hydrophobic nature38.  Also, the F mRNA has a long, G-C rich non-coding 
region at the 5’ terminus that may play a role in the regulation of protein synthesis38.  
Computer modeling also suggested that long stretches of α-helices were responsible for 
membrane interactions during fusion38.  Some of these features are also found in HIV 
gp120 and influenza HA44. 
 The F protein contains two 4-3 heptad repeats, characterized by hydrophobic 
residues in recurring positions, next to the fusion peptide and the transmembrane domain 
that may be important for inhibiting fusion44.  The protein is found as a trimer on the 
surface of cells and is believed to form a six-helix bundle during the fusion process44.  
Lateral mobility is required for both F and H in order to undergo fusion45.  The fusion 
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peptide, leucine zipper, transmembrane region, and cytoplasmic tail of F are not 
important for its interaction with H46.  The region of importance was narrowed down to 
the cysteine rich region of the F protein, which has long been suspected to play a role in 
the fusion process46. 
 The H protein is the main determinant of viral tropism based on receptor binding, 
but its role in viral fusion is still contentious47.  There are three main ideas: 1) The H 
protein is not strictly required.  Through receptor binding it helps to bring the viral 
membrane within close proximity of the host PM, thereby increasing fusion efficiency.  
2) The H protein interacts with the F protein and, upon ligand binding, induces a 
conformational change in F, which exposes its hydrophobic domain.  3) Binding of H to 
the receptor sends a signal to the host cell or the virion to initiate the fusion process45.  
There is little experimental evidence in support of the third idea, but a wealth of data 
support both the first and second ideas.   
 Experiments with micelles containing the F protein showed that fusion is possible 
if an agent is added to bring individual micelles together48.  Also, certain paramyxovirus 
F proteins, when expressed alone, can induce fusion.  These include SV5, peste des petits 
ruminants virus, and MV F expressed in an adenovirus vector49, 50, 51.  In most of these 
examples, coexpression of the H protein often enhances fusion and may be its main 
determinant52.  However, other paramyxoviruses have required both H and F to be 
expressed to induce fusion, such as Rinderpest virus, NDV, and SV4150, 53, 54.  Using a 
vaccinia virus construct, Wild et al. showed that for measles virus, both H and F are 
required for fusion55.  Human parainfluenza virus 2 (hPIV2) also required both proteins 
for fusion, although they did not have to be expressed on the same cell surface54, 56.  The 
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most likely explanation for the disparate results lies in the different expression systems 
used57.   
A salient feature of fusion is that when H is required, it must be from the same 
virus as F.  Using H from one virus and F from a closely related virus does not usually 
result in fusion.  Evidence like this suggests that H does play an active role in the fusion 
process and does not simply bring the membranes close together.  Researchers have 
exploited this phenomenon and used it to produce H protein chimeras.  With this strategy, 
hPIV2 researchers have narrowed the region of H necessary for fusion down to the 
transmembrane and the stalk regions54.  Interestingly, the globular head does not play a 
role54.   
 Further evidence from mutational analyses also supports the role of H in the 
fusion process.  The H protein is 617 amino acids long and contains one hydrophobic 
transmembrane domain58.  It naturally occurs as a tetramer on the surface of the host 
cell59.  Studies with human parainfluenza virus 3 (hPIV3) and Newcastle disease virus 
(NDV) showed that this interaction is important for fusogenicity.  The specificity of the 
interaction resides in the transmembrane region and first 82 amino acids of the 
ectodomain, but not in the cytoplasmic tail or globular head60.  This was also observed in 
Sendai virus61.  In addition, conserved leucines in heptad-repeat motifs in the 
transmembrane domain are important for tetramer formation, and mutation of these 
conserved residues resulted in decreased fusogenic activity62.   
In contrast, studies in measles virus have shown that the cytoplasmic domain of H 
may play a role in fusion.  Moll et al. found that the cytoplasmic tail of H could only be 
truncated to 14 residues before it began to affect the ability of H to augment the fusion 
 13 
ability of F63.  The cytoplasmic tail of F was not important though, as it could be 
truncated to 3 amino acids without adversely affecting fusion.  It was also noted that the 
tyrosine residue at position 481 is particularly important for cell fusion64.  By adding an 
eight amino acid tag to the H protein of MV, Plemper et al. were able to diminish the 
interaction between H and F on the host cell surface65.  Surprisingly, this weaker 
interaction resulted in increased and earlier syncytium formation65.  
 Also supporting an active role for H in membrane fusion is the identification of 
monoclonal antibodies to NDV and Sendai virus that block receptor binding but do not 
inhibit fusion66, 67.  The studies in NDV showed that some antibodies could even 
differentiate virion-cell from cell-cell fusion66.  Additionally, the receptor has been found 
to play a role in fusion.  Studies with CD46 showed that by varying the length of the 
receptor, researchers could increase viral binding while concomitantly decreasing 
fusion68.   
 Seemingly at odds with other evidence, and in support of the hypothesis that H 
triggers a conformational change in F, experiments with NDV identified a point mutation 
in the globular head of H that disrupted receptor recognition, neuraminidase activity, and 
fusion activity45, 69.  The mutation also disrupted H and F interactions at the cell surface, 
as shown by coimmunoprecipitation experiments.  The authors argued that if receptor 
recognition triggers interaction with F and fusion, then a mutation that abolishes receptor 
recognition should also abolish fusion, which these experiments have shown69.  If H is 
only needed to bring the membranes in close proximity, then disrupting the interaction 
between H and F should not affect fusion.  
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 The physical and biological properties involved in fusion are not yet fully 
understood.  Most of the research conducted has used syncytia induction as its final read 
out, which is useful for understanding cell-cell fusion, but may not be entirely relevant 
for virus-cell fusion.  In fact, studies have shown that the two processes are not entirely 
identical66.  Although the role of H in fusion has not been conclusively proven 
experimentally, the majority of data suggests it does more than simply bring the two 
membranes into close proximity.  What that role is exactly remains controversial.  
Because the fusion of two lipid bilayers is such a fundamental biological process, 




 The essence of viral replication is to produce infectious progeny.  For RNA 
negative-strand viruses, it is a process that requires two distinct phases, both of which 
occur in the cytoplasm70.  In the first phase, the genome is transcribed into functional 
mRNAs.  Once accomplished, the virus now faces the task of replicating its genome 
through a positive strand intermediate.  To prevent annealing between the positive strand 
and the nascent genome, the RNA is always associated with the N protein71.  The 
replication machinery of RNA viruses also has very little proofreading activity, causing 
RNA viruses to mutate up to 10,000 times faster than organisms that use DNA71.  The 
high mutation rate ultimately restricts the size of the viral genome, with most RNA 
viruses having genomes between 5 and 15 kilobases71.       
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For morbilliviruses, the replication complex is believed to be composed of an 
association between the phosphoprotein (P) and large (L) proteins, with all of the 
catalytic activity contained in the L protein72.  The MV L protein is composed of 2183 
amino acids that are highly conserved among negative strand viruses36.  The P protein is 
only 507 aa and is activated by phosphorylation36.  For measles virus, the major cellular 
kinase responsible for phosphorylation is casein kinase II73.  The L-P binding site has 
been mapped to the N-terminal 408 amino acids of the L protein, which contains the first 
of six conserved domains74.  The amino terminal of the P protein is also important for 
binding to L36. 
 As noted, the L protein is highly conserved among the negative strand viruses and 
contains glycine-asparagine-asparagine (GDD) residues flanked by strong hydrophobic 
regions, which are believed to be remnants of an ancestral RNA polymerase75.  Sequence 
comparisons between morbillivirus L proteins have shown that MV and Rinderpest virus 
are closely related, as are CDV and PDV76.  The comparisons have also revealed six 
highly conserved domains separated by less conserved regions77.  Three of the domains in 
the N-terminal half of the protein are conserved amongst the paramyxo-, filo-, and 
rhabdoviridae78.  The conserved domains are believed to contain the enzymatic functions 
of the protein.  The carboxy terminus displays higher variability and may contain virus-
specific functions79.    
The L proteins are unusual in that they have high leucine/isoleucine content and 
are basic80.  Domain I is important for binding to the P protein, which may in turn 
regulate binding to the RNA-N template81.  Studies in Sendai virus have shown that 
mutations at amino acid 368 and a three amino acid insertion at 379 almost completely 
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disrupt complex formation and RNA synthesis82.  Domain II contains a charged, RNA 
binding motif81.  The functions of the remaining domains have not been fully 
characterized.  The domains have been extensively mutated, with various effects on RNA 
synthesis, but the precise function of each domain has remained unclear81.  
 The nucleocapsid protein must be bound to the viral RNA in order for 
transcription and replication to proceed.  The N protein is 525 amino acids long and is the 
most abundant viral protein due to its 3’ position on the negative-sense RNA36.  It is 
believed to interact with genomic RNA, the P protein, and itself in order to form the 
ribonucleoprotein complex83.  Following synthesis on free ribosomes, the N protein is 
folded and rapidly incorporated into the viral nucleocapsid84.  Deletion analysis has 
shown that amino acids 4-188 and 304-373 are required for the formation of the N-P 
complex85.  In order to achieve efficient replication of the morbillivirus genome, the total 
length must be a multiple of six.  The rule-of-six is presumably due to the functional 
binding unit of the nucleoprotein, which is six nucleotides70.  The association of each N 
protein with the RNA chain probably begins at the 5’ end and continues to the 3’ end.  If 
the genome is not a multiple of six, a few nucleotides will overhang at the 3’, preventing 
efficient initiation by the polymerase70. 
 The viral RNA polymerase transcribes the first strand leader RNA followed by 
the viral RNAs in the following order: 3’-N-P+C-M-F-H-L-5’86.  The L protein is 
responsible for capping, methylating, polyadenylating, and editing all of the mRNAs81, 87.  
As transcription proceeds, the RNA polymerase moves from one coding region to the 
next, but occasionally falls off and does not reinitiate at downstream gene junctions, 
generating an mRNA gradient from 3’ to 5’88.  The relative mRNA amounts compared to 
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N have been quantified to be P (81%), M (67%), F (49%) and H (39%)772.  The RNA 
polymerase activity is dependent on NTP precursors and divalent cation89.   
 Following transcription, the genome is replicated via the antigenome, its 
complementary copy.  The switch from transcription to replication is due to an 
accumulation of free N protein70.  To synthesize the antigenome, it is thought the same 
polymerase copies the same template, but ignores the gene junction signals70.  Synthesis 
of the genome from the antigenome is thought to occur by a similar process, but there are 
no reinitiation sites on the antigenome, so replication proceeds smoothly.  The leader 
sequence also plays an important role in the regulation of transcription and replication.  
Most of the monocistronic N mRNAs lack the 55 nucleotide-long leader sequence, while 
all of the plus-strand genomes contain it90.  This led to the hypothesis that the leader 
RNA determines whether RNAs are destined for encapsidation or translation.  It has also 
been proposed that the rapid accumulation of the leader sequence may play a role in 
down-regulating host cell transcription91.   
 Host cell proteins appear to play a role in measles virus replication, although they 
have not been clearly defined.  Actin has been detected in the virion and studies in human 
parainfluenza virus 3 (hPIV3) have shown that NP and P interact with the cytoskeletal 
framework92.  Treatment of cells with cytochalasin D, which disrupts the cytoskeletal 
network, diminishes RNA synthesis by 70%92.  Actin may play a role in the budding 
process by dragging the assembled ribonucleoprotein to the surface during filament 
elongation.  Cell-free transcription systems with measles virus have shown that β-tubulin 
is required for efficient transcription and replication in vitro, although 
coimmunoprecipitation experiments showed that α-tubulin associated with the L 
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protein93.  These results were also observed in VSV and Sendai virus, but have not been 
shown in vivo93.  Further studies have also identified host cell proteins that interact with 
the genomic 3’ noncoding region and the plus strand leader sequence.  Using RNA 
footprint analysis, Leopardi et al. have shown that a 20 kDa protein binds to the 3’ 
noncoding region and 22 and 30 kDa proteins interact with the leader sequence, but the 
proteins have not been identified94. 
 The P mRNA is polycistronic and encodes three other non-structural proteins- C, 
V, and R36, 95.  The V protein is produced by RNA editing, where the viral RNA 
polymerase inserts a single, non-templated G residue following a string of 3 genomically 
encoded G residues at position 75136, 96.  Therefore, the V protein has the same 231 
amino-terminal residues as the P protein, but contains a unique 68 amino acid carboxy 
terminus.  The amino terminal region contains the phosphorylation sites and one of the 
two N-interaction sites97.  The unique carboxy terminus contains seven highly conserved 
cysteine residues, which form a zinc binding domain98.  Yeast two hybrid experiments 
failed to find an interaction between V and N, suggesting rather that V interacted with 17, 
38, and 60 kDa host cell proteins, but other studies have found an interaction between V 
and N necessary to balance viral transcription97, 99.  In rinderpest virus, V interacts with 
both N and L100.   
 The C gene initiation site is encoded 19 nucleotides downstream of the P gene 
start site in the +1 reading frame36.  Although measles virus only encodes one C protein, 
other paramyxoviruses encode up to four, and use alternate start codons101.  Like the V 
protein, it is unclear if C interacts with other proteins.  The C protein has been shown to 
form complexes with host cell proteins, and in RPV, to interact with the L protein99, 100.  
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The different assays and cell systems used are the most likely explanations to account for 
these observations.  The precise functions of the V and C proteins have remained elusive.   
 The C and V proteins are not strictly required for measles virus replication in 
vitro, but mutations or deletions in either gene can affect viral RNA synthesis in vivo97, 
102, 103.  In both MV and RPV, defects in the V protein lead to increased synthesis of viral 
RNA and proteins while also increasing syncytium formation97, 104.  Without the C 
protein, viral RNA synthesis is reduced in MV-infected PBMC’s or in RPV-infected cell 
lines104, 105.  In vivo, V- or C-deficient viruses replicate slower and show less 
pathogenicity, suggesting the proteins may play a role in avoiding host defense systems97, 
106.  Interleukin-1β, IL-12, and TGF-β levels were comparable between mutant and wild-
type viruses, but TNF-α and RANTES levels were lower in mice infected with mutant 
virus103.  
 Once transcription has produced mRNAs, they are translated by the host 
ribosomes.  The final protein products must then be sorted to the proper intracellular 
location, processed, and transported to the plasma membrane.  Likewise, the nascent viral 
genomes must also find their way to the cell surface in order for assembly to proceed.          
 
Protein Sorting and Interaction with Lipid Rafts 
 Once measles virus has completed its genome replication, it faces the task of 
assembling its ribonucleoprotein complex, consisting of the genomic RNA along with the 
N, P and L proteins.  The RNP and remaining structural proteins, M, H and F, must then 
be transported to the plasma membrane where they associate to produce a mature viral 
bud.  The efficiency of nucleocapsid formation and the final structure may be regulated 
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by the P protein107.  Several lines of evidence suggest that the main mediator of viral 
transport and assembly at the plasma membrane is the M protein. 
 The morbillivirus M gene is 335 amino acids long and has a molecular weight of 
38 kDa108, 109.  The carboxy-terminal third of the protein is most highly conserved and 
contains a hydrophobic sequence, which may interact with the lipid bilayer109, 110.  The M 
protein is thought to have two or three functional domains; one to interact with the inner 
leaflet of the plasma membrane, another to interact with the nucleocapsid, and possibly a 
third that binds to actin.  The M protein interacts with the nucleocapsid across the plasma 
membrane at the cell surface111.  This interaction was blocked by cytochalasin B, 
suggesting a role for actin in the process111.  The M protein also interacts with the viral 
RNP, which may inhibit RNA transcription112.  The role of M in protein sorting and 
assembly is complicated by the pathogenesis of the virus.    
Measles virus is spread via respiratory droplets and initially infects and replicates 
in respiratory tract epithelial cells.  In addition, in order to spread, the virus must also find 
its way back into the lung expirate so that it can be transmitted from individual to 
individual.  Because epithelial cells are polarized, there may be viral mechanisms for 
entering the apical surface of lung epithelium upon infection.  Likewise, the virus may 
induce the cell to preferentially sort it to the apical or basolateral surface following 
infection.   
This question was first addressed in the polarized vero cell line C1008, a monkey 
kidney line, and Caco-2 cells, a human intestinal epithelial cell line.  In both cell types, 
virus added to the apical side of the cell was able to replicate much more efficiently than 
virus added to the basolateral side113.  Virus release was also polarized, with titers from 
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the apical medium being 1000-fold higher than those from the basolateral medium113.  
This finding was later extended to the Madin-Darby canine kidney (MDCK) cell line, the 
best-studied cell line for polarized sorting of proteins114.  Repeated passages of the virus 
induce more efficient release from the basolateral side115.  When primary cultures of 
well-differentiated human airway epithelial cells were used, it was found that the virus 
preferentially transduces the basolateral side and is released from the apical side116.  The 
reason for this discrepancy is unclear, but it may be related to the surface expression of 
the viral receptors.  The CD46 receptor is preferentially expressed on the apical side of 
C1008, Caco-2, and primary epithelial cells, while the expression of SLAM in polarized 
cells has not been studied yet113, 116. 
For many viruses, polarized release is thought to relate to the cellular localization 
of the envelope proteins, although measles virus appears to have developed a strategy that 
is different than that used by other viruses117.  Following translation, H and F are folded 
by chaperones in the endoplasmic reticulum, where they first associate, forming hetero- 
and homo-oligomers118, 119.  In Sendai virus, the M protein binds to H and F as it transits 
through the Golgi network, although this has not been shown for measles virus120.  As 
they progress through the sorting pathway, F is proteolytically cleaved into F1 and F2 in 
the trans-Golgi prior to sorting.  Measles virus H and F are then found on the apical and 
basolateral membranes of MDCK and CaCo2 cells114, 121.  Although the virus buds 
apically, basolateral expression of the glycoproteins may help the virus to spread by cell-
cell fusion.  In support of this idea it was found that both H and F contain a basolateral 
targeting signal, which can be overridden by mutating a single tyrosine in the cytoplasmic 
tails, amino acid 12 in H and 549 in F122.  In addition, the cytoplasmic tails of H and F 
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could redirect the influenza H7 protein, which normally sorts apically, basolaterally.  
These signals also serve to initiate endocytosis, although viral infection appears to block 
this function122.   
Since H and F contain intrinsic basolateral sorting signals, they must interact with 
other viral proteins in order to bud apically.  Studies of virus isolated from subacute 
sclerosing panencephalitis patients (SSPE) revealed the role of the M protein in assembly 
and budding.  SSPE viruses are usually defective in virion production and spread by cell-
cell fusion123.  Most viruses isolated from SSPE patients had a defective M protein and 
altered cytoplasmic tails in their fusion proteins124.  These defects abrogated binding 
between M and the viral nucleocapsid123, 125.  Several of the SSPE mutants have shown a 
biased hypermutation where the most common mutation is often a U to a C126.  It was 
found that the M protein interacts with the cytoplasmic domain of F and when defective 
M proteins were incorporated into virions, increased fusion was observed, which is 
associated with basolateral sorting127, 128.  Additionally, studies in polarized epithelial 
CaCo2 cells showed that in the absence of M the envelope glycoproteins preferentially 
sort to the basolateral surface.  When the M protein was added, the glycoproteins were 
found on the apical side121.  The M protein preferentially associates with the apical side 
of MDCK and CaCo2 cells, but in transfected cells M is not found at the plasma 
membrane121.  This suggested other factors present in a full infection were needed for M 
to be transported to the plasma membrane129.   
The additional factors may include components of the cytoskeleton, particularly 
actin.  Early transmission electron microscope studies showed viral particles associated 
with actin filaments, with 76% of the filament’s barbed ends protruding into budding 
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virus130.  Observations like these led the authors to speculate that the vectorial growth of 
actin filaments played a key role in viral budding.  Studies in Sendai virus have supported 
the idea that actin is involved131, 132.  Wild-type Sendai virus buds apically from MDCK 
cells, but a mutant, F1-R, buds in a bipolar fashion131, 132.  Both glycoproteins are found 
apically and basolaterally.  Treatment of the cells with depolymerizing drugs also 
resulted in bipolar release of mature virions, suggesting the mutation in the F1-R strain 
results in a defective interaction between the M protein and the cytoskeleton135.  Blocking 
actin filaments in MV-infected cells leads to a drastic decrease in the production of 
infectious virus134.   
 Membrane proteins are sorted in the trans-Golgi network for targeting to the 
plasma membrane or intracellular compartments, depending on the signals they contain.  
N-glycans and GPI anchors can be used as apical sorting signals while basolateral signals 
originate from the cytoplasmic domains of proteins135.  While it is known that basolateral 
transport uses the same machinery as synaptic vesicle transport and ER-Golgi transport, 
the mechanisms used for apical transport are not well known.  The ribonucleoprotein 
complex, which consists of the genomic RNA, nucleoprotein, viral polymerase, and the 
phosphoprotein, assembles in the cytoplasm.  The RNP must then enclose itself in a host-
derived membrane that is enriched in the M, F, and H proteins to initiate viral budding.  It 
is thought that M interacts with actin, which is also found in the virion.  By interacting 
with actin, the growth of actin filaments can transport the RNP from the cytoplasm to the 
PM, but whether or not the transport is mediated by M has not been shown72.  The matrix 
protein, which lines the inside of the membrane, binds to the cytoplasmic tail of F and 
may concentrate the F and H proteins at the assembly site to facilitate budding.    
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 The location of viral assembly and budding has been postulated to be lipid rafts so 
that viral proteins can be concentrated while host proteins are selectively excluded.  To 
support these ideas, recent research has shown that the M, N, H, and F proteins are 
selectively enriched in lipid raft regions of the PM136.  The M protein may act as the 
organizing center for viral budding since it appears to concentrate the H and F proteins 
along with the ribonucleoprotein complex at virus assembly sites.  Early structural studies 
showed that viral assembly probably occurs at the PM137, 138.  When lipid raft regions are 
isolated, infectious virus can be recovered.  Gerlier et al. found that 15-40% of H and F 
colocalize with the raft fragments, while 35% of M and 25% of N did so136.  The 
nonstructural V protein, as a control, was predominantly recovered from the soluble 
fractions.  Further studies showed that M and N could attach to rafts independent of 
interactions with H or F136.  Time course studies revealed that maximal attachment of raft 
proteins occurred between 4 to 6 hours following synthesis139.  
 Although a lot of research has been done on intracellular sorting, transport, 
assembly, and budding, many questions remain.  Conflicting results have been published 
regarding polarized epithelial cell sorting, and the in vivo situation remains unclear.  The 
actual cellular machinery involved in apical sorting has yet to be characterized, and 
studies of viral protein sorting pathways may help illuminate this aspect of cell biology.  
Finally, the biology behind budding is only now beginning to be understood.  The recent 
discovery of lipid rafts has invigorated the field, and should help clarify this aspect of the 
viral life cycle.   
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Alteration of Cellular Immunity 
 Measles virus is renowned for its ability to suppress the immune response of the 
host organism.  The high mortality associated with measles is attributed to the 
immunosuppressive effects of the virus and the host’s subsequent susceptibility to 
secondary infections.  Vaccination also results in a suppression of the DTH response, 
although it is much more mild140.  The cellular and molecular mechanisms behind the 
immune suppression are coming to light, but it is a complicated problem.   
 The finding that monocytes are a main target of the virus in vivo and in vitro 
opened the door to more thorough studies of the immunesuppression141, 142.  In addition, 
neonatal monocytes were noted to be particularly susceptible143.  It was subsequently 
discovered that measles virus infection specifically down-regulated IL-12 production 
from monocytes, which was replicated by cross-linking the CD46 receptor144.  It has been 
suggested that monocytes and macrophages serve as a barrier to protect DC’s, which 
present MV antigens most efficiently, from becoming infected and also serve as vectors 
to transport the virus from the periphery to regional lymph nodes145, 146, 147.  The 
maturation state of the cell also influences susceptibility, as monocyte precursors are 
readily infected and produce higher amounts of infectious virus148.  It was also found that 
maturation leads to cellular changes that block viral replication posttranscriptionally and 
posttranslationally148.  These results do conflict with the known expression of SLAM, 
which is found primarily on activated and mature cells, although precursor cells have not 
been specifically looked at.  It is also generally accepted that activated cells are more 
permissive to the virus149.  
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 For over two decades it has been known that MV infection can disrupt the cellular 
production of the type I interferons, interferon-α and β, which are the main anti-viral 
cellular defense.  In 1977 it was shown that attenuated strains of the virus induced 
significantly more interferon than wild-type strains150.  The low production of interferon 
led to high viral titers151.  Later studies showed that wild-type infection partially blocked 
STAT1α and STAT1β production, which are in the interferon α/β signaling cascade152.  
If cells are preinfected with wild-type virus, they can block interferon production by 
subsequent infection with attenuated virus, but not dsRNA-induced interferons152.  In 
mice transgenically modified to express CD46, the interferon α/β receptor needs to be 
knocked out in order to get efficient spread of the virus, demonstrating the potent effects 
of this response146.  Sendai virus also blocks interferon production, particularly through 
its AUG114-initiated C protein153.  The mechanism is believed to be through inhibition of 
an α/β responsive promoter although a direct link has not been established154.  SV5 also 
inhibits the promoter in human cells154.  
 A second facet of the immune suppression is that viral infection blocks the 
mitogen-stimulated proliferation of lymphocytes in culture.  The virus appears to block 
the cell cycle progression at the G1 phase in both lymphocytes and thymic epithelial 
cells155, 156.  The effect on thymic epithelial cells may be particularly important in 
children, who still have a developing immune system.  All members of the morbillivirus 
family block proliferation and it has been shown with measles virus that expression of the 
H and F proteins alone is sufficient157.  Fusion with the host cell membrane is not 
required158.  It has also been suggested that there is a separate suppressive pathway that 
only requires the interaction between H and CD46, but this may not occur in vivo159.  
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Another mechanism has also been identified in T cells where MV infection has been 
shown to block the IL-2 pathway by blocking the activation of Akt kinase160.        
 In addition to blocking proliferation, morbilliviruses may also induce apoptosis in 
infected cells.  When SCID mice with grafted human thymuses were infected with 
virulent measles virus, there was a 100-fold decrease in the number of viable 
thymocytes161.  This study also showed that thymic epithelial cells were infected161.  
Peste des petits ruminants virus induces apoptosis in goat PBMC’s162.  In addition to the 
thymus, the bone marrow may also be infected during measles, supporting the idea that 
immature cells are susceptible163. 
 The mechanisms of immune suppression are complex and multifaceted.  New 
technologies have the potential to provide important clues for understanding the 
complicated interactions between the virus and the host immune system.  By deepening 
our knowledge of this complex effect, scientists will gain insight into many areas of 
biology, and hopefully this insight will help to find new strategies for combating these 
devastating viruses.   
 
Microarray Analysis 
Microarrays are one such technology that gives scientists a new view of old 
problems.  Due to the large amount of data generated, harnessing the power of 
microarrays requires a lot of computer power and the proper use of statistics.  This next 
section will briefly review the Affymetrix GeneChip® system and the statistical methods 
that provide the best results to date. 
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The Affymetrix GeneChip® system uses approximately eleven 25-oligomer 
probes scattered across a gene to measure the expression level of that gene.  For each 
probe there is a perfectmatch (PM) and mismatch (MM), which differs from the PM at 
the 13th nucleotide to serve as a background binding control.  The probe values are then 
assembled to determine a gene expression value (referred to as signal intensity in the 
normal Affymetrix protocol).  The signal intensity is usually normalized and examined 
for expression differences, but it has been shown that normalizing probe level data can be 
advantageous164. 
Normalization is an important consideration when analyzing gene array data in 
order to minimize the variation due to non-biological variables (i.e. the scanner) and to 
maximize the detection of biological variability.  The standard Affymetrix normalization 
does not work well with nonlinear relationships between chips, which often occur in gene 
array experiments165.  Several normalization options exist, see Bolstad et al. for a more 
complete review, but quantile normalization is preferred because it is robust, 
computationally fast, and does not rely on choosing samples for a baseline165, 166.  
Quantile normalization does assume that a small percentage of the genes are significantly 
changing, which has been observed in many Affymetrix experiments and specifically in 
DC maturation experiments165, 167.       
Following quantile normalization, probe intensities were assembled into gene 
expression values with Robust Multi-Array Analysis (RMA), also developed by Irizarry 
et al.168.  Again, a number of options exist to assemble probe level data, most of which 
incorporate both the PM and MM probe values, either as PM-MM or PM/MM.  
Experiments have shown that as the target gene concentration increases the MM 
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expression value also increases, demonstrating specific binding169.  One study found over 
80% of the mismatch signal, especially at higher concentrations, is from interactions with 
target transcripts170.  Li and Wong reached a similar conclusion164.  Therefore, RMA does 
not include MM values in the calculations, resulting in a similar accuracy but better 
precision than some commonly used algorithms as well as providing more consistent 
estimates of fold change165, 169.  The differential expression calls are also more specific 
and sensitive, especially at lower fold change values.  For a more thorough discussion, 
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 Gene expression patterns supply insight into complex biological networks that 
provide the organization in which viruses and host cells interact.  Manipulation of this 
network by viral proteins causes pathogenesis following infection.  In this report we 
examine the gene expression changes that occur following dendritic cell infection with 
measles virus over the course of 24 hours.  There were 1553 significantly regulated genes 
with nearly 60% of them down regulated.  The dendritic cells up regulated many 
expected genes such as interferons, interleukins, chemokines, and other antiviral agents, 
while down regulating genes required for protein synthesis and oxidative 
phosphorylation.  The histone, metallothionein, and insulin-like growth factor binding 
protein gene families were identified as significantly up-regulated genes that have not 
been well characterized in infection models.  The measles virus-infected dendritic cell 
results were then compared to eight other pathogen-host cell systems.  These results 
provide a modular view of dendritic cell biology in response to infection. 
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Introduction 
 Measles virus (MV) is remarkable for its ability to induce a generalized and 
prolonged immune suppression concordant with a productive, specific immune response 
following infection.  Measles virus-specific immunity is life-long while the transient 
immune suppression is responsible for most of the mortality associated with measles 
virus, which still claims 770,000 children each year1.  This is particularly troublesome 
considering the existence of a safe, effective vaccine.  However, immunological barriers, 
including maternal antibody and a developing immune system, prevent effective 
vaccination of infants in endemic areas before 9 months of age2.   
Viral transmission is via respiratory droplets.  The initial replication occurs in 
lung epithelial cells before the virus spreads to local lymphoid tissue to replicate in 
macrophages and monocytes, eventually reaching the blood2, 3.  It has been suggested that 
dendritic cells (DCs) play a role in transporting the virus from the lungs to the lymph 
nodes, but it has not been demonstrated that DCs are infected in vivo4, 5.  In support of 
this idea, DCs generated from CD34+ cells, monocytes, or Langerhans cells can be 
infected with laboratory, wild type, or chimeric strains of MV in vitro6, 7, 8.  However, it 
has also been shown that as promyelocytic and promonocytic cells mature there is a 
decreased production of infectious virus, which is also seen in DCs9, 10.   
 Dendritic cells are the most potent initiators of the immune response, but some 
evidence suggests these functions may be compromised during infection.  In culture, 
CD40-induced DC maturation was altered by MV infection, which inhibited CD40-
CD40L signaling between DCs and CD8+ T cells7.  Infected DCs also produce low 
amounts of interleukin-12 (IL-12), inhibit mitogen-dependent proliferation of peripheral 
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blood mononuclear cells (PBMCs), and fail to stimulate T cells in mixed lymphocyte 
reactions6, 10, 11.  Reports differ on whether the virus must replicate in order to impair DC 
function6, 12.  Measles virus may also induce Fas-mediated apoptosis in DCs to facilitate 
viral release, while up-regulating tumor necrosis factor-related apoptosis-inducing ligand 
(TRAIL) to induce apoptosis in lymphocytes10, 12, 13, 14. 
 Gene array analysis is a powerful technique that provides a global view of gene 
expression patterns, but thus far has mainly illuminated the role of individual genes.  
Specifically regulated pathways will most easily be revealed by gene expression 
comparisons between similar systems.  Comparisons between labs are currently hindered 
by the wide variety of array platforms, incomplete datasets, and the analysis techniques 
used.  Despite these limitations, we show that meaningful comparisons can be made 
which elucidate biological insights. 
 
Materials and Methods 
Cell Isolation and Culture 
 Donor blood was acquired by the Johns Hopkins Hemapheresis Center operating 
under an institutionally approved protocol.  PBMCs were isolated over a Ficoll-Hypaque 
gradient and viability was verified by trypan blue exclusion.  Ten million cells/ml were 
cultured overnight in RPMI-1640 supplemented with 30% autologous human serum at 
37°C and 5% CO2.  The next day, the cells were washed with phosphate-buffered saline 
(pH 7.2)(PBS) and adherent cells were removed with gentle scraping.  The adherent 
monocytes (CD14+) were 70.59 ± 18.01% pure as determined by flow cytometry.  To 
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increase purity, the B cells, T cells, and granulocytes were removed using magnetic bead 
separation (Miltenyi Biotech, Auburn, CA), which gave 86.30 ± 7.30% pure CD14+ cells.   
 The enriched CD14+ cells were cultured at a concentration of 5x105 cells/ml in 
RPMI-1640 media supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 2 
mM HEPES, 100 µM non-essential amino acids, 100 units/mL penicillin, 100 µg/ml 
streptomycin (Gibco, Grand Island, NY), 1000 U/ml of interleukin-4 (IL-4), and 50 ng/ml 
of granulocyte-macrophage colony stimulating factor (GM-CSF) (BD Biosciences, San 
Diego, CA).  The cells were cultured at 37°C in 5% CO2.  The media and cytokines were 
replaced every two days.  On day 6 the cells were treated with 200 ng/ml 
lipopolysaccharide (LPS, Sigma-Aldrich, St. Louis, MO) or infected at a multiplicity of 
infection (MOI) of 5 with the Chicago-1 strain of MV and incubated for 1 hour at 37°C in 
5% CO2.  The cells were then washed and resuspended in fresh media and cytokines.    
Virus Preparation 
Chicago-1 strain MV was used to infect vero cells at .005 MOI.  After 4 days of 
culture the cells were frozen at –80°C, thawed, and cellular debris was removed by 
centrifugation.  Virus was concentrated by spinning at 80,000 x g for 1 hour at 4°C.  
Aliquots of these stocks were grown in antibiotic-free media for 14 days to verify lack of 
contamination.   
Flow Cytometry 
Cells were blocked with 10% donor human serum in PBS for 20 minutes, washed, 
and stained for 1 hour on ice using a panel of monoclonal antibodies including mouse 
anti-human CD80, CD86, CD83, HLA-DR, CD1a, CD14 and the appropriate isotype 
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controls (BD Biosciences).  Analysis was performed using a FACScalibur flow cytometer 
and CellQuest software (BD Biosciences).   
RNA Isolation and cDNA Synthesis 
Total RNA was isolated from control cells and at 3, 6, 12, and 24 hours post-
infection using the RNeasy Kit (Qiagen, Valencia, CA) and following the manufacturer’s 
protocol.  Gene array analysis was performed on Affymetrix GeneChip® U95Av2 
(Affymetrix, Santa Clara, CA) following the manufacturer’s protocol.  Briefly, 15 µg of 
RNA was used to synthesize cDNA in two steps using the Superscript Choice System 
(GibcoBRL, Rockville, MD) and the reverse transcription primer T7-(dt)24, 
[5’GGCCAGTGAATTGTAATACGACTCACTATAGGGAGG CGG(T)24] (GENESET 
Corp., La Jolla, CA).  For one set of timecourse data (0, 3, 6, 12, and 24 hours), an equal 
amount of RNA from two separate experiments was pooled to yield sufficient RNA for 
gene array analysis.  Following cDNA synthesis, the product was purified using phase 
lock gels (Brinkmann Instruments, Westbury, NY).   
cRNA Synthesis 
The cDNA product was used to synthesize biotin-labeled cRNA with the 
BioArray™ High Yield™ RNA Transcript Labeling Kit (Enzo Diagnostics, Inc., 
Farmingdale, NY) following the manufacturer’s protocol.  After the in vitro transcription 
reaction, unincorporated nucleotides were removed using the RNeasy Kit.  The cRNA 
was then precipitated, washed twice with 80% ethanol, dried, and resuspended in RNAse-
free water.  The RNA was quantified and 20 µg were fragmented by metal-induced 
hydrolysis.  The products were verified by gel electrophoresis. 
Hybridization, Staining, and Scanning 
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The fragmented cRNA was hybridized to the human U95Av2 GeneChip® array 
(Affymetrix) along with 50 pM control oligo B2 (5’ bioGTCAAGATGCTACCGTTCAG 
3’) (Affymetrix), with the control RNA of Bio B (150 pM), Bio C (500 pM), Bio D (2.5 
nM), and Cre X (10 mM) (Affymetrix), and 0.1 mg/ml herring sperm DNA (Promega, 
Madison, WI).  Hybridization was done at 42ºC and 60 rpm in a hybridization oven 
(Affymetrix) for 16 hours.  The chips were washed using the Affymetrix fluidics protocol 
EukWSH-4 and stained with streptavidin-phycoerythrin (Molecular Probes, Inc., Eugene 
OR) at a final concentration of 10 µg/ml in 6x SSPE buffer containing 1 mg/ml 
acetylated bovine serum albumin (Sigma-Aldrich).  The chips were washed twice and 
scanned with the HP GeneArray Scanner (Hewlett-Packard, Santa Clara, CA).  
Normalization and RMA 
The affy package, developed by Irizarry et al. as an add-on to the software 
package R, was used to analyze the gene array data15.  MVA plots revealed that the 
greatest distortion occurred at the lowest expression levels (data not shown).  Background 
correction, normalization and summarization were done using quantile normalization and 
robust multiarray analysis (RMA).  The processed data set is available at the GEO 
website, accession number GSE980 (www.ncbi.nlm.nih.gov/geo/).  
SAM 
Significance was determined using Significance Analysis of Microarrays 
(SAM)16.  For this analysis, four control and three experimental samples were compared 
using the two-class, unpaired algorithm at two timepoints, 6 and 24 hours.  The 
significantly regulated genes identified at each timepoint were combined.  Only genes 
with a fold change of 2.0 or more were considered for significance.  A false discovery 
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rate (FDR) under 10% at the 90th percentile was chosen.  The results are shown in 
Supplementary Table 2.1.   A higher threshold, with an FDR under 1% at the 90th 
percentile, was also examined and yielded similar conclusions (data not shown). 
Comparisons 
 Comparisons were made to three other published experiments: 1) Huang et al. 
treated DCs with Candida albicans, mannose, Escherichia coli, LPS, influenza virus, and 
double-stranded RNA (polyinosine-polycytidine, PIC), over 36 hours, 2) Vahey et al. 
treated PBMCs with HIV over 72 hours, and 3) Browne et al. treated human foreskin 
fibroblasts with human cytomegalovirus (HCMV) over 48 hours17, 18, 19.  The Huang data 
is available at http://web.wi.mit.edu/hacohen/dc, while the Vahey and Browne data are 
available from the GEO website, accession numbers GSE511 and GSE675, respectively.  
The results from these studies were handled the same as the MV data when possible, 
however the raw data from Huang et al. and Vahey et al. was not available so the 
background subtraction, normalization and summarization procedures were different.  
The SAM results for C. albicans, E. coli, and influenza virus from the Huang et al. study 
are shown in Supplementary Table 2.1.  The LPS, mannose, and PIC samples could not 
be tested because they were only done in duplicates.  No significantly regulated genes 
were found in the Vahey et al. study and the Browne et al. study did not have replicates 
so significantly regulated genes could not be determined.   
Gene Annotation 
The significantly regulated genes were annotated using Database Referencing of 
Array Genes Online (DRAGON) to assign SWISS-PROT keywords, SWISS-PROT 
subcellular localizations, and KEGG pathways20, 21, 22, 23.  None of the classifications were 
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exclusive.  An enrichment score was calculated for the SWISS-PROT keyword 
annotations where the enrichment score for a given keyword=((Significantly regulated 
genes with keyword)/(Total genes with keyword))/((Total significantly regulated 
genes))/(Total genes on chip))24. 
Graphing 
Replicate measurements at each timepoint were averaged and divided by the time 
0 mean to get the fold change.  Duplicate genes were averaged.  Probes from the 
HuGeneFL chip at times overlapped two or more probes on the U95Av2 chip.  In these 
cases, the U95Av2 probe with the highest % similarity to the probe on the HuGeneFL 
chip was graphed.  The graphs show the average fold change (except for HCMV, where 
the lines connect the actual measurements).  Individual points represent the actual gene 
expression measurements.  The DC controls and duplicate genes could have up to 15 
measurements at each timepoint, but only three randomly chosen measurements were 
displayed.  The PBMC control and HIV samples were normalized such that they could 
contain negative values, which are undefined on the log scale and were not plotted.   
 
Results 
Dendritic Cell Maturation 
PBMCs were isolated from leukopheresis products and cultured with GM-CSF 
and IL-4 for six days.  The cells showed the expected immature DC surface marker 
phenotype: CD14-, CD1a+, CD83-, CD80low, CD86low and HLA-DRlow  (Supplemental 
Figure 2.1).  These immature monocyte-derived DCs were treated with 5 MOI of 
Chicago-1 strain MV or 200 ng/ml of LPS.  In agreement with previous results, flow 
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cytometric analysis at 24 hours post-infection revealed that the cells had matured in 
response to the stimulation by down regulating CD1a and up regulating CD83, CD80, 
CD86 and HLA-DR in a manner similar to cells stimulated with LPS (Supplemental 
Figure 2.1)7, 25.  The mRNA expression changes for these molecules, derived from the 
gene array experiments (see below), concur with the flow cytometry results, except for 
HLA-DR, which is known to be stored intracellularly in immature DCs and is transported 
to the plasma membrane following maturation (Supplemental Figure 2.2)26.  (Similar 
results from the comparison experiments are shown in Supplementary Figure 2.2.  See 
below).  Total RNA was isolated and used for gene array analysis and RT-PCR at 0, 3, 6, 
12, and 24 hours post-infection.     
Gene Array Analysis 
RNA from control and MV-infected DCs was isolated and used in gene array 
analysis using the Affymetrix GeneChip® system.  Normalized expression values were 
used in Significance Analysis of Microarrays (SAM).  We limited the false discovery rate 
to 10% at the 90th percentile and a fold-change > 2.0 for determining significance.  In the 
MV-infected DCs there were 622 significantly up regulated genes and 931 down 
regulated genes.  We compared our results to dendritic cells treated with other pathogens 
and found 47 up regulated genes in C. albicans-treated DCs, 106 up regulated genes in E. 
coli-treated DCs, and 72 up regulated genes in influenza-treated DCs.  There were very 
few down regulated genes found in these studies, so they were not analyzed further.  A 
summary of the significantly regulated gene results is shown in Supplementary Table 2.1.  




The significantly regulated genes were annotated with SWISS-PROT keywords 
using DRAGON.  Only groups with enrichment scores >2.0 that contained at least 10 
genes from the measles data (or 5 from the Huang et al. data) were analyzed further.  The 
results for the up regulated and down regulated keyword groups are shown in Tables 2.1 
and 2.2, respectively.  Approximately 20% of the genes could not be classified or were 
unknown using this method.  The complete keyword results are available in 
Supplemental Tables 2.6 and 2.7.  The most up regulated classifications included 
anticipated results such as interferon induction, antiviral, inflammatory response, 
cytokine, chemotaxis, and SH2 domain (Table 2.1).  Genes from these groups overlap 
with the prenylation, apoptosis, growth factor, signal anchor, and zinc groups.  All of 
these classifications were up regulated in each DC sample.  There were some surprising 
results as well, such as the metal-thiolate cluster classification induced by all of the 
pathogens and the chromosomal protein classification largely induced by measles 
infection. 
 The different statistical procedures used made it difficult to compare the 11 
experiments in a systematic way, so it was important to examine the gene expression 
changes individually.  Note that in the graphs all of the genes in a particular group are 
shown for completeness, but this does not mean they were significantly regulated.  The 
significantly regulated genes found in each grouping are provided in Supplemental 
Tables 2.8-2.12.   
The interferon-induced group was composed of genes for well-known IFN-
induced proteins like chemokines, 2’5’-oligoadenylate synthetase (OAS), Mx, interferon-
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regulatory factors (IRF), interferon-induced genes (IFI) and proteasomal components 
(Sup Figures 2.3-2.14).  Nearly all of the treatments induced the OAS, Mx, IRF1, and 
IRF7 genes.  In addition, gene names containing “interferon-induced” were strongly up 
regulated in DCs, but less so in PBMCs and fibroblasts.  Interestingly, dsRNA-dependent 
protein kinase (PKR) was induced by every treatment except measles (Figure 2.1).  This 
result was verified by RT-PCR.  The chemokines CCL5, CCL8, CCL19, CXCL2, 
CXCL10 and CXCL11 were up regulated by all the DC treatments.  CCL1, CCL2, 
CCL7, CCL15, CCL20, CXCL3, and CXCL9 were differentially regulated between 
treatment groups.  Another DC maturation marker, CCR7, was strongly induced in DCs 
by all treatments at the earliest timepoints, except for PIC where it was not induced until 
24 hours post-treatment. 
 The second induced group had the keyword antiviral and was composed of the 
interferon and Mx genes.  Measles virus induced all of the interferon-α genes except 
IFNA8, while influenza virus induced IFNA1, IFNA2 and possibly others, but more 
weakly than measles (Figure 2.2).  None of the other treatments induced interferon-α 
genes.  Interferon-β and interferon-ω were strongly induced by measles and interferon-γ 
was weakly induced, while the other pathogens had unique patterns (Figure 2.3).  
Biologically active interferon from MV-infected DCs was measured with a cellular 
protection assay, which found that it increased through 12 hours and maintained that level 
through 24 hours (Figure 2.4). 
 The third classification group was metal-thiolate cluster, which was composed of 
genes from the metallothionein family (Figure 2.5).  Genes in this family are responsible 
for binding trace metals, i.e. zinc, and have not been well described in the immune 
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response.  Metallothioneins-1G and -1H are potently induced in all of the DC systems, 
but not in PBMCs or fibroblasts.  Five of the seven MT1 genes were significantly 
regulated in measles virus-infected DCs, but not as strongly as in the other systems. 
 The inflammatory response group was mostly chemokines, while the cytokine 
group was composed of chemokines, colony-stimulating factors (CSF), interferons, 
interleukins, and members of the TNF superfamily (TNFSF, Sup Figures 2.15-2.18).  
Measles significantly up regulated a variety of interleukins, including IL-1β, -6, -8, -11, -
12A, -12B, and –15.  Measles also induced the most TNF superfamily members, with 
members 1, 2, 4, 7, 8, and 10.  The other DC samples induced TNFSF1 and TNFSF10 
while HCMV uniquely induced TNFSF9 and TNFSF10. 
 The chromosomal protein group was mostly composed of histone 1, H2b and H1 
family members (Sup Figures 2.19-2.22).  Many histone genes are increasing in the other 
treatments, but were not significantly regulated, possibly due to their low fold change 
values and large variability. 
The down regulated classifications fall into five general groups (Table 2.2).  The 
first group contains the highly connected ubiquinone, hydrogen ion transport, inner 
membrane, NAD, mitochondrion, transit peptide, and oxidoreductase groups.  The genes 
in these classifications encode the proteins that form the five complexes of the oxidative 
phosphorylation machinery: NADH dehydrogenase, succinate-Q reductase, ubiquinol-
cytochrome c reductase, cytochrome c oxidase, and ATP synthase (Sup Figures 2.23-
2.27).  The second group includes the ribosomal proteins and the largely overlapping 
classifications initiation factor, protein biosynthesis, and helicase.  These groups contain 
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both nuclear and mitochondrial ribosomal proteins and the eukaryotic translation 
initiation factor family members (Sup Figures 2.28-2.33). 
The third group is the chromatin regulators, which are composed of histone 
deacetylase genes and chromobox homologs (Sup Figures 2.34-2.35).  The last two 
groups, lysosome and DNA repair, had a mixture of genes but no readily identifiable 
gene groups.  
Subcellular Localization and Pathway Identification 
 The significant genes were also annotated and grouped according to their SWISS-
PROT subcellular localization.  Table 2.3 shows that most locations had the same relative 
ratio of up-regulated to down-regulated genes (≈0.7), except for the secreted, microsomal 
and type II membrane proteins, which were induced, while the mitochondrial and 
lysosomal/endosomal localizations were depressed.  These results support the 
classifications shown in Tables 2.1 and 2.2, where the dendritic cells are beginning to 
secrete a large number of immunomodulatory factors while the mitochondrial respiratory 
chain and lysosome are shutting down. This classification procedure yielded new 
biological insights also, such as insulin-like growth factor binding proteins (IGFBP) from 
the secreted group.  Measles, influenza, and E. coli-infected DCs secreted IGFBPs 4 and 
6 while HIV-infected PBMCs produced IGFBP2 (Sup Figure 2.36). 
 A final way to look at the results is to use the KEGG database, which groups 
genes according to pathways or protein complexes.  Only those pathways that had at least 
ten regulated genes are shown in Table 2.4.  Three immune signaling pathways were 
induced: MAPK, Toll-like receptor, and Jak-STAT signaling pathways.  The Toll-like 
receptor pathway was increased by all of the pathogens, while the Jak-STAT pathway 
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was increased by measles, C. albicans and E. coli, and the MAPK pathway was up-
regulated by measles and E. coli (Sup Figures 2.37-2.43).   
The KEGG classification method was the only one to highlight the interleukin, 
chemokine, and TNF receptors (Sup Figures 2.44-2.47).  Again, the DC experiments 
showed differences with the PBMCs and fibroblasts, with IL2RA, IL7R, IL10RA, and 
IL15RA mRNAs being induced in most of the DC samples while IL1R2 was down 
regulated.  The final up regulated pathways, apoptosis and calcium signaling, included 
genes from the NF-κB family (Sup Figure 2.48).  
The most down regulated pathway was oxidative phosphorylation, which 
overlapped with ATP synthesis, followed by ribosomes.  The cell cycle, focal adhesion, 
and regulation of actin cytoskeleton were composed of a diverse array of genes. The 
down regulated genes from the calcium signaling pathway included ATPases, adenylate 
cyclases and solute carrier family members, which were seen in the keyword 




 We have analyzed the gene expression changes of dendritic cells infected with 
MV over the course of 24 hours and compared the results to other pathogen-host cell 
systems.  We have generated a list of 1,553 significantly regulated genes that increase or 
decrease by 2-fold or more after exposure of immature, monocyte-derived DCs to MV.  
With this large dataset we were able to identify cellular pathways and compartments that 
are changing significantly following infection. 
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Many of the up regulated genes coded for known antiviral or interferon-induced 
proteins, but unexpected observations included genes in the histone and metallothionein 
families.  The cellular antiviral response to MV has not been extensively characterized, 
with a few studies describing the interferons, OAS, IRF, and Mx genes27, 28, 29, 30, 31, 32, 33, 
34, 35. Measles virus induces IFN-α/β and IL-6 in lung epithelial cells, consistent with our 
findings in DCs36.  Microarrays were also used to study measles virus infection of 
PBMCs at 48 hours37.  Of the ten induced genes identified in their study, six were on the 
U95Av2 chip and 5 of those, NF-κB p52, IRF7, 2’5’-oligoadenylate synthetase, IFN-α 
and IFN-β were significantly up regulated in our study. 
Interestingly, although most treatments did not induce interferons to a large 
extent, interferon-induced genes were strongly induced, suggesting there may be an 
alternative signaling mechanism for the induction of these genes.  Because the interferon-
α results for measles virus are so uniform it is difficult to conclude that the probes are 
independently measuring the different interferon-α genes, although they seemed to act 
more independently in the influenza system.  Nevertheless, the results show that 
microarrays, with independent confirmation, could be a powerful tool to study the 
interferon system in different virus-host cell systems to determine when the different 
interferon-α genes are expressed.   
This study also found a number of new genes involved in the innate immune 
response to pathogens such as members of the histone, histone deacetylase, chromobox 
homolog, metallothionein, and IGFBP families.  In addition, IL-11, IL-15 and a number 
of TNF superfamily members have not been studied in the context of measles virus 
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infection.  These are only the characterized genes, and the microarray data identified 321 
unclassified genes significantly regulated during the response (Sup Table 2.2).  
It has long been observed that host cell transcription and translation are altered 
during viral infection38.  This is being confirmed by numerous gene array studies, which 
often find more down regulated genes than up regulated genes following viral infection.  
In addition to our study, this has also been described in herpesvirus-infected endothelial 
cells, vaccinia virus- and influenza virus-infected HeLa cells, HIV-infected CD4+ T cells, 
and human cytomegalovirus-infected fibroblasts39, 40, 41, 42, 43.  This down-regulation is 
probably due to replicating virus, as Browne et al. showed that UV-inactivated virus 
down regulated significantly fewer genes than the live virus19.  Few down regulated 
genes were found in the comparison data examined in this study, probably because the 
normalization procedures used failed to reduce the signal-to-noise ratio, making it 
difficult to detect significantly regulated genes at low expression levels. 
Two large gene groups were down regulated following MV infection: oxidative 
phosphorylation and protein biosynthesis.  Although the shutdown of host protein 
synthesis has been previously observed, the shutdown of oxidative phosphorylation is an 
unexplored area.  Whether shutting down oxidative phosphorylation is an antiviral 
response, part of the apoptotic process, or has some other role in the virus-host 
relationship is quite unclear.  Genes in the lysosome, DNA repair, cell cycle, focal 
adhesion and regulation of actin cytoskeleton classifications did not fall into any clear 
groups.  These classifications may represent emergent properties, because the genes 
would not normally be grouped together except for their role in a particular biological 
process.  The down regulation of lysosomal genes supports the hypothesis that DCs, upon 
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maturation, switch from a highly phagocytic, antigen-processing cell to a potent antigen-
presenting cell44.  The role the genes present in other classifications are playing in the 
immune response is not clear. 
Currently, the varying array platforms, analysis algorithms, and annotation 
schemes make it difficult for laboratories to compare results.  In addition, experimental 
differences, such as the treatment dose and duration, complicate analysis further.  Despite 
these limitations, we found that it is possible to compare results from different systems 
and obtain meaningful results.  These findings also suggest that the use of standard 
experimental designs and statistical procedures will increase the resolution of microarray 
data comparisons, yielding new insights into cell biology.  
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Table 2.1 Significantly up regulated genes classified by SWISS-PROT keyword. 
 
 Measles C. albicans E. coli Influenza 
SWISS-PROT Keyword Up Down ES Up ES Up ES Up ES 
Interferon Induction 29 1 12.9 12 49.5 13 22.7 18 52.7 
Antiviral 11 0 10.1 1 8.7 1 3.7 3 18.6 
Metal-thiolate Cluster 6 0 8.7 2 21.2 5 22.5 2 15.0 
Inflammatory Response 17 6 5.8 6 22.9 11 17.8 5 13.5 
Cytokine 45 5 5.7 10 13.3 17 9.6 11 10.3 
Chemotaxis 16 4 5.2 4 11.9 9 11.3 4 8.4 
Chromosomal Protein 13 3 3.6 0 0 1 1.0 1 1.6 
Prenylation 17 12 2.7 1 2.1 1 0.9 1 1.5 
Apoptosis 29 11 2.5 2 2.3 7 3.4 2 1.6 
Growth Factor 16 5 2.3 2 3.2 5 3.3 3 3.4 
SH2 Domain 14 13 2.3 1 2.0 1 0.9 2 2.9 
Signal-anchor 16 10 1.5 2 2.4 3 1.5 5 4.2 



































SWISS-PROT Keyword Up Down 
Enrichment 
Score 
Ubiquinone 0 13 6.4 
Ribosomal Protein 0 36 4.3 
Hydrogen Ion Transport 0 13 3.5 
Inner Membrane 0 15 3.5 
Chromatin Regulator 2 12 3.4 
Initiation Factor 1 12 3.3 
NAD 3 32 3.1 
Mitochondrion 11 82 2.7 
Transit Peptide 6 58 2.7 
Protein Biosynthesis 3 17 2.5 
Oxidoreductase 14 66 2.3 
Lysosome 1 14 2.2 
DNA Repair 1 17 2.1 
Helicase 0 13 2.0 
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 Table 2.3 Significantly regulated genes classified by SWISS-PROT subcellular 
localization. 
 
Measles C. albicans E. coli Influenza SWISS-PROT  
Subcellular Localization Up Down Up Up Up 
Unclassified 266 403 15 39 31 
Membrane      
     Integral 38 72 4 10 6 
     Type I 36 53 3 7 1 
     Type II 18 10 2 3 5 
     Miscellaneous 20 27 0 0 0 
Nuclear 104 167 6 9 8 
Cytoplasmic 82 148 7 13 6 
Mitochondrial 16 75 2 2 2 
Secreted 78 25 13 23 13 
Golgi/TGN 4 10 0 0 0 
Endoplasmic Reticulum 8 14 0 0 0 
Lysosomal/Endosomal 1 27 0 0 0 
Peroxisomal 4 5 0 0 0 
Extracellular 2 3 0 0 0 









    





   



























































































































































































































































































































































































































































Figure 2.1 dsRNA-dependent protein kinase gene expression.  Timecourse 
graphs of the PKR gene are shown for each of 11 conditions.  DCs were treated
with media, MV, C. albicans, E. coli, influenza, LPS, mannose or PIC.  PBMCs
were treated with media or HIV and fibroblasts were treated with HCMV.  RNA
was collected at various timepoints and expression levels were measured by
microarray analysis.  The lines show the mean fold change, normalized to the











































































































Figure 2.2 Interferon-α gene expression.  Timecourse graphs for interferon-α

























































































Figure 2.3 Interferon-β, -γ and -ω gene expression.  Timecourse graphs for
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Figure 2.4 Production of biologically active IFN by MV-infected DCs.  Points












































































































































Figure 2.5 Metallothionein gene expression.  Timecourse graphs for the 



















Changes in PBMC Gene Expression During Acute Measles 
 
 


























 Measles virus continues to cause a great deal of morbidity and mortality despite 
the existence of a safe and efficacious vaccine.  In this study we looked at the gene 
expression changes that occur during acute measles infection and convalescence in 
peripheral blood mononuclear cells (PBMCs).  We found 13 significantly up regulated 
genes, including the cytokines interleukin-1β (IL-1β) and tumor necrosis factor (TNF) 
and the chemokines interleukin-8 (IL-8), CXCL2 and CCL4.  There were 206 down 
regulated genes, which were mainly involved in three biological processes: transcription, 
signal transduction and the immune response.  These results help understand the 
pathogenesis of acute measles virus infection. 
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Introduction 
 Measles virus is remarkable for the robust immune response it elicits in the face 
of a generalized immune suppression that lasts several weeks following acute infection.  
After infection of the respiratory epithelium, the virus is thought to travel to the regional 
lymph nodes via DCs or macrophages where it incubates for 10-14 days1.  The virus 
replicates in lymphoid tissue and spreads throughout the body, triggering a robust 
immune response that starts with IgM antibody production to N at the time of the rash2.  
Eventually, antibodies are made to most MV proteins, with the predominant serotype 
being IgG1 followed by IgG4, IgG2 and IgG32, 3. 
 The CD8 T cell response is known to be important for viral clearance and immune 
memory.  Patients with agammaglobulinemia develop the characteristic rash and recover 
from the disease, showing immunity to further exposure4.  CD8+ T cells from normal 
patients have been shown to proliferate in response to MV-infected cells, which causes 
the characteristic rash5, 6.  During the time of the rash there is significant evidence of 
immune activation including an increase in sCD4, sCD8, sIL-2R, neopterin (produced by 
activated macrophages), sFas, sFasL, and sTNFR7, 8.  Every arm of the immune system is 
not activated though as NK cell activity is decreased during acute disease9.  
Lymphoproliferative responses to MV antigen and DTH responses are also severely 
repressed1, 10.  
 A number of cytokines have been measured in the serum of infected patients 
during the immune response.  IFNγ is detected early in the response and quickly returns 
to baseline shortly after the rash appears11, 12, 13.  IL-2, IL-4, IL-13 and IL-10 were also 
elevated during acute infection with IL-4 and IL-10 persisting for several weeks 
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following viral clearance11, 14.  IL-5 and IL-12 levels were lower than controls, while 
TNF and IL-1β are undetectable11, 13, 15, 16.  These findings lead to the hypothesis that the 
early immune response is characterized by a Th1 type response followed by a prolonged 
Th2 response that lasts for several weeks and contributes to the immune suppression17.  
In this study, microarrays were used to globally survey mRNA levels in PBMCs to 
understand other immune changes that may be occurring during acute infection and 
convalescence.  
 
Materials and Methods 
 Samples of peripheral blood were collected from children with measles at study 
entry, hospital discharge and 1-month follow-up in sterile tubes containing EDTA at the 
University Teaching Hospital in Lusaka, Zambia as previously described18.  White blood 
cell counts and differential WBC counts were performed manually.  IgM EIA confirmed 
measles infection and all children were negative for HIV infection.  PBMCs from 5 
children with measles and 3 controls were separated on Ficoll-Hypaque, washed and 
stored in RNAzol or RNA-Stat  (Tel-Test, Inc., Friendswood, TX) at -80°C and at a later 
time RNA was isolated following the manufacturer’s protocol.  RNA quality assessment 
was determined by RNA Nano LabChip analysis on an Agilent Bioanalyzer 2100 
(Agilent, Palo Alto, CA).  All studies were done with protocols approved by both Johns 
Hopkins University and University Teaching Hospital. 
Affymetrix GeneChip Protocols  
For each sample, 100 ng of total RNA was processed according to the 
amplification protocol from the Affymetrix GeneChip Eukaryotic Small Sample Target 
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Labeling Technical Note, version 1 (Affymetrix, Santa Clara, CA). The protocol features 
two cycles of amplification, each containing a cDNA synthesis step followed by an in 
vitro transcription reaction to generate cRNA.  The second IVT synthesis incorporates 
biotinylated ribonucleotides to produce labeled antisense cRNA targets for hybridization.  
Fifteen micrograms of cRNA were fragmented by metal-induced hydrolysis in 
fragmentation buffer (250mM Tris acetate pH 8.1, 150 mM MgOAc, 500mM KOAc) at 
94o C for 35 minutes.  Hybridization cocktails were prepared as recommended for arrays 
of “Standard” format and applied to Affymetrix Human Genome U133A GeneChips. 
Hybridization was performed at 45oC for 16 hours at 60 rpm in the Affymetrix rotisserie 
hybridization oven.  The signal amplification protocol for washing and staining of 
eukaryotic targets was performed in an automated fluidics station (Affymetrix FS450) as 
described in the Affymetrix Technical Manual, Revision Three.  The arrays were then 
transferred to the GCS3000 laser scanner (Affymetrix) and scanned at an emission 
wavelength of 570nm at 2.5 mm resolution.  Intensity of hybridization for each probe pair 
was computed by GCOS 1.1 software. 
Exploratory data analysis was performed on the samples using R v2.2.0 and the 
add-on package affy v1.5.819, 20.  Background correction, normalization, and 
summarization were performed using Robust Multi-Array Analysis20.  Significance 
testing was performed with Significance Analysis of Microarrays (SAM) v2.21 on 
controls versus each of measles entry, discharge, and follow-up21.  A gene was 
considered significant if it had a fold change >2.0 and a false discovery rate (FDR) <15% 
at the 90th percentile.  There were no significantly regulated genes at entry, 224 at 
discharge, and 32 at follow-up.  The results were pooled and duplicate genes were 
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averaged, leaving 13 up regulated genes and 206 down regulated genes.  The genes were 
then annotated with the June 20, 2005 Affymetrix release and grouped into gene 
ontologies with Onto-Express using the default settings22.  Only groups with a corrected 
p-value < 0.05 and including 5 or more genes were considered in the analysis.  Genes 
were also annotated with Swiss-Prot keywords, subcellular localizations and KEGG 
pathways using Database Referencing of Arrays ONline (DRAGON)23.   
 
Results 
 Children with acute measles were admitted to the University Teaching Hospital in 
Lusaka, Zambia, where blood was collected following an institutionally approved 
protocol.  Table 3.1 shows the clinical characteristics of the subjects.  Both boys and girls 
were included ranging in age from 9 months to 79 months. Collected samples were 
calibrated by the number of days since the individual first developed a measles rash, 
which is typically 12-17 days after infection1. The median number of days post-rash at 
entry, discharge and follow-up were 4, 8 and 40, respectively.   
The patient WBC counts, % lymphocyte, % CD4+ and % CD8+ T cells closely 
resemble those reported for the larger study from which these samples were drawn 
(Figure 3.1) 18.   The WBC counts are slightly elevated at discharge and follow-up with a 
lower lymphocyte percentage that increased to control levels by discharge.  The CD4 
percentages were lower at entry than control as has been reported, although they returned 
to baseline by follow-up in the larger study.  These patients have slightly lower % CD4 at 
follow-up than the cohort average.  The CD8 percentages were also very similar, 
although the controls in this study were on the low end of the larger control group. 
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 RNA extracted from PBMC at each timepoint was run on microarrays.  There 
were 13 significantly up regulated genes and 206 significantly down regulated genes.  
The complete results are shown in Supplemental Table 3.1.  Significant genes were 
annotated with Onto-Express and DRAGON.  The significant groups for the gene 
ontology biological processes annotation are shown in Table 3.2.  The only up regulated 
groups were signal transduction and apoptosis, which overlapped significantly.  The 
genes found in these groups included the cytokines IL-1β and TNF and the chemokines 
CCL4, CXCL2, and IL-8 (Figure 3.2).  The up regulated genes all peaked at discharge 
and declined at follow-up, but not down to the control level.   
 The down regulated classifications fell into three broad biological processes: 
transcription, signal transduction and the immune response (Table 3.2).  Transcription 
had the largest number of genes and included four classifications: regulation of 
transcription, DNA dependent, transcription, regulation of transcription from RNA 
polymerase II promoter and nuclear mRNA splicing, via spliceosome.  The largest gene 
groups in these classifications were zinc finger proteins and transcription factors.  These 
genes were being down regulated at entry and most of them hit their lowest expression 
levels at discharge and began to recover by follow-up, though not back to the control 
level (Supplemental Figure 3.1).   
The second biological process was signal transduction, which included nine 
receptor genes and eight kinases.  The immune response classifications included IL-16, 
IL-4R, IL-6R, IL-7R, IL-27RA, TNFSF3, CCR2 and CCR7.  The cytokine and 
chemokine receptors had the lowest expression at discharge and did not fully recover by 
follow-up (Figure 3.3).   
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The subcellular localization of the proteins encoded by the significant genes is 
shown in Supplemental Table 3.2.  The number of up regulated secreted proteins and 
down regulated nuclear genes were found to be significant using OntoExpress.  The 
KEGG pathway, Swiss-Prot keyword and molecular function annotations supported the 
biological process results (Supplemental Tables 3.3-3.6). 
 
Discussion 
 This study examined the gene expression changes in PBMCs from children 
infected with MV at hospital entry, discharge, and at 1-month follow-up.  There were 13 
up regulated genes and 206 down regulated genes.  A number of the up regulated genes 
identified in this study have been examined in measles and other viral infections. IL-1β is 
a potent inflammatory cytokine produced by macrophages that is responsible for inducing 
fever and activating T cells and macrophages24.  IL-1β mRNA is found up-regulated in 
MV-infected monocytes, glial cells, meningeal fibroblasts and a malignant glioma cell 
line25, 26, 27.  Increased IL-1β protein was detected in the cerebrospinal fluid of SSPE 
patients and is produced by cultured PBMCs taken from patients during the convalescent 
phase of infection28, 29.  
 TNF-α is another potent inflammatory cytokine and endothelial cell activator24.  
Its gene expression was also significantly up regulated in these patients, but this has not 
been consistently observed in other studies.  Glial cells and malignant glioma cells have 
increased expression after MV infection, but meningeal fibroblasts and monocytes do 
not25, 26, 27.  TNF-α protein levels are normal in the cerebrospinal fluid of SSPE patients 
and production by PBMCs is reduced during the acute phase of infection28, 29.  
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Interestingly, TNF-α plasma levels and production by PBMCs from vaccinees is 
increased, suggesting there may be a difference between natural infection and vaccination 
in TNF-α production30, 31.  ICAM-1 is expressed on lymphocytes, monocytes and 
neutrophils and is up regulated during inflammation32.  It may serve as a costimulatory 
receptor for APC-T cell interactions and enhances antigen presentation33.  It has been 
found to be higher in SSPE patients and following MV infection of astrocytes28, 34. 
 There were several chemokines significantly regulated by measles virus, with 
CCL4 (MIP-1β), CXCL2 (GRO-β) and IL-8 being up regulated.  CCL4 is produced and 
secreted by activated macrophages to attract other proinflammatory cells, such as CD4+ 
T cells or DCs to attract memory cells35.  The chemokine has no effect on DCs and little 
on NK cells36, 37, 38.  The only known receptor is CCR5, which is preferentially up 
regulated on Th1 cells and consequently, CCL4 has more activity for Th1 cells than Th2 
cells37, 39, 40.  It has also been shown that high amounts of CCL4 at the site of T cell 
activation will favor a Th1-type response41. 
 CXCL2 and IL-8, which are structurally related, were also up regulated in 
response to measles42.  The GRO family is produced by macrophages and serve as 
chemoattractants for neutrophils and basophils, but have little activity toward 
monocytes42, 43, 44, 45, 46.  Previously, an increase in GRO-α (CXCL1) was observed during 
measles infection47.  IL-8 is made by monocytes, T cells, neutrophils, fibroblasts, 
endothelial cells and epithelial cells to attract neutrophils, basophils and T cells24, 37.  
Both IL-8 and CXCL2 bind to CXCR2, but IL-8 also binds to CXCR137.  This may 
partially explain why IL-8 is more potent than CXCL2 for attracting neutrophils45.  
CXCL2 may contribute to lung injury during viral infection44, 48.  The available IL-8 data 
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also supported our findings as the bronchial epithelial cell line, A549, produces IL-8 
following MV infection and it is also increased in the plasma of infected monkeys 3 days 
post-infection49.  
  The down regulated genes found in this study have not been well characterized in 
MV infection, although IL-16 plasma levels were measured in this cohort and were 
significantly down regulated at follow-up50.  Microarray analysis showed that IL-16 was 
significantly down regulated at discharge and remained below the levels of control at 
follow-up.  The discrepancy may reflect the time required to see a difference due to a 
change in gene regulation manifested in the serum. 
 There were two down regulated chemokine receptors, CCR2 and CCR7.  CCR2 is 
highly expressed on monocytes, activated and memory T cells (both Th1 and Th2) and is 
down regulated when monocytes differentiate into macrophages39, 41, 51.  It has two forms 
and both bind MCP1 (CCL2), 3 (CCL7) and 5 (CCL12), which are potent attractors of 
monocytes and T cells24, 37.  Both TLR2 and TLR4 agonists down regulated CCR2 and 
measles H protein has been shown to activate TLR252, 53.  Consistent with our findings, 
Candida-treated monocytes down regulated CCR254.  
 CCR7 is expressed on naïve T cells, activated B and central memory T cells, but 
it is absent on effector memory cells55, 56, 57.  CCR7- cells express receptors for migration 
to inflamed tissues and display immediate effector function, suggesting the down 
regulation seen during acute measles could be due to the ongoing T cell effector 
response1, 58. 
 Several studies have looked at gene expression changes in PBMCs following 
infection or disease.  Patients with autoimmune diseases showed distinct patterns 
 67 
compared to acute measles infection59.  PBMCs from SARS patients showed no up 
regulation of cytokines or other molecules involved in an adaptive immune response.  
Most of the genes up regulated were of the innate immune system60.  Smallpox virus-
infected monkeys showed up regulation of a number of genes involved in cell cycle 
regulation, as well as immune modulators61. SIV-infected macaques sampled at 3 and 7 
weeks had two down regulated zinc finger proteins similar to measles, but otherwise 
showed quite different responses62.  CXCL2 was up regulated in LPS challenged humans, 
but the down regulated genes were involved in respiration, protein synthesis and 
degradation63.  Acute measles changes were most similar to those induced by HIV 
infection in humans, where signal transduction, immune response and transcription were 
also large down regulated groups64. 
Since the cell composition of the PBMC compartment is changing during this 
time (Figure 3.1), it is possible that the gene expression changes are due to alterations in 
the cell composition.  However, since the largest alterations in cell composition occurred 
at entry and there were no significantly regulated genes at this time, this suggests that the 
significantly regulated genes at follow-up and discharge may reflect gene expression 
changes.  By purifying blood cells and sampling more timepoints, gene expression 
analysis could contribute more understanding to measles virus pathogenesis. 
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Table 3.1 Clinical characteristics of patients and controls. 
  Days post-rash at: 
 
Age 
(Months) Sex Entry Discharge Follow-up 
Control 1 26 Female NA NA NA 
Control 2 15 Male NA NA NA 
Control 3 9 Male NA NA NA 
Patient 1 21 Male 3 8 61 
Patient 2 79 Female 2 4 36 
Patient 3 9 Male 7 11 41 
Patient 4 11 Female 4 9 39 




Table 3.2 Significant genes grouped by GO biological process. 
 





7165 Signal transduction 6 1.64E-05 
6915 Apoptosis 5 2.49E-07 
 
Down Regulated 
6355 Regulation of transcription, DNA-
dependent 
35 .0019 
6350 Transcription 30 .0012 
7165 Signal transduction 24 .038 
6468 Protein amino acid phosphorylation 13 .031 
6955 Immune response 12 .0040 
6357 Regulation of transcription from RNA 
polymerase II promoter 
11 .0025 
398 Nuclear mRNA splicing, via spliceosome 7 .018 
7166 Cell surface receptor linked signal 
transduction 
6 .019 
19735 Antimicrobial humoral response (sensu 
Vertebrata) 
6 .0023 




















































































































Figure 3.1 Blood lymphocyte counts for patients with acute measles virus
infection.  The individual counts are shown for each patient with filled circles
while the median value is displayed with an “X”.  The days post-rash are
shown by (c)ontrol, (e)ntry, (d)ischarge and (f)ollow-up, which correspond





























Figure 3.2 Up regulated genes.  The mean and standard deviation of the fold
change for each gene is shown.  The days post-rash are shown as in Figure 
3.1.  CIAS1- cold autoinflammatory syndrome 1.  IER3- immediate early 
response 3.  ICAM1- intercellular adhesion molecule 1.  IL- interleukin.  
PDE4B- phosphodiesterase 4B.  PTGS2- prostaglandin-endoperoxide 
synthase 2.  G0S2- putative lymphocyte G0/G1 switch gene.  TNF- tumor 




















Figure 3.3 Examples of down regulated cytokine receptors and chemokine
receptors.  The mean and standard deviation of the fold changes for each











Measles Virus Vaccination in BALB/c Mice 


























 Measles vaccination has reduced morbidity and mortality for humans in many 
parts of the world, but there are still a significant number of deaths in large parts of 
Africa and Southeast Asia.  Although a safe and efficacious vaccine is in widespread use, 
it has not completely penetrated these endemic areas because it is ineffective in infants 
less than 6 months of age due to protection from maternal antibody and the immaturity of 
the infant’s immune system.  As measles virus eradication is an elusive and important 
goal, it would be useful to design a vaccine that can be given earlier in life, preferably at 
birth.  In this study we evaluated a new alphavirus replicon particle expressing the 
measles virus H protein (VCR-H) and the formalin-inactivated measles vaccine (FIMV) 
in mice.  The results show that both vaccines induced significant antibody production, but 
only the VCR-H vaccine induced a robust interferon-γ response.  Microarray analysis 




Enders and Peebles isolated the original vaccine strain of measles virus, 
Edmonston, in the 1950’s using a monkey kidney cell line1.  The strain was passaged on 
human renal and amnion cells and then in chick embryos to attenuate it2.  This live 
attenuated vaccine (LAV) induced a robust immune response but it did have some mild 
side effects, which could be lessened by giving γ-globulin at the time of vaccination3, 4.  
To attenuate the vaccine further it was again passaged in chick embryos.  These 
additional passages resulted in the Schwarz and Moraten vaccine strains, both of which 
had fewer side effects following vaccination than the Edmonston strain, but also had a 
lower seroconversion rate5, 6.  The LAV induced seroconversion in 95% of individuals 
after one dose7, 8, 9, 10, 11. 
Another approach to vaccination for measles was to inactivate the virus with 
formalin and saturate it with alum.  This formalin-inactivated measles vaccine (FIMV) 
was well tolerated, but it required three doses to achieve 90% seroconversion7, 12, 13, 14. In 
addition to the lower seroconversion rate, the antibody levels induced by the inactivated 
vaccine began dropping within a few months after vaccination, causing many individuals 
to quickly lose protection7.  When some of these individuals were exposed to circulating 
virus, they developed an atypical disease that was first described by Rauh and Schmidt15.  
They found that 43.2% of children given the three doses of killed vaccine developed 
natural measles, modified measles or a more severe atypical disease within the next 2.5 
years.  Many other groups described atypical disease and found it could occur decades 
after the original vaccination, even if the individual had received the LAV in the 
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interim16, 17, 18.  Other inactivated paramyxovirus vaccines have also been found to 
predispose to a more severe disease after natural infection19, 20. 
 After studying individuals with atypical measles, it was found that the antibody 
profile in those people was different from those who received the LAV.  Specifically, the 
LAV induced antibodies against both H and F while the killed vaccine only induced 
antibodies against H21, 22, 23, 24, 25, 26.  It was postulated that the lack of these antibodies 
allowed the virus to spread from cell to cell so the vaccine was not protective, but H 
protein was continually produced which induced a hyperimmune response that caused the 
atypical disease21, 26.  This hypothesis was never proven in vivo though. 
In the 1990’s, a monkey model of the atypical disease was developed which 
provided many insights. Monkeys given the FIMV had lower levels of IL-12, higher IL-4 
and increased neutrophils27.  The monkeys given FIMV did not develop a high-affinity 
antibody response, while the LAV monkeys did28.  Experiments also showed that the 
atypical disease was the result of immune complex formation and increased 
eosinophilia29.  
 Measles virus eradication is hindered by the immaturity of the infant immune 
system.  Studies have shown that the responses in infants are qualitatively different from 
the responses in adults30.  Passive antibodies from the mother also inhibit seroconversion 
to the vaccine, whether the mother has had wild measles infection or the vaccine 
herself31.  A number of approaches have been taken to developing a new measles vaccine 
including using vesicular stomatitis virus, vaccinia virus and salmonella as vectors, 
administering the vaccine through aerosol or just producing a DNA or RNA vaccine 
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32, 33, 34, 35, 36, 37, 38.  In this paper we compare the immune responses and gene expression 
patterns of mice immunized with a new alphavirus replicon particle vaccine and the 
formalin-inactivated vaccine.  
 
Materials and Methods 
Vaccinations and Cell Isolations 
 All mouse work was completed under an institutionally approved protocol.  
Female 5-6 week old BALB/c mice were vaccinated in the rear footpads with saline (30 
µl + 40 mg/ml lactose), a previously described chimeric Sindbis virus-VEE replicon 
construct containing the complete coding sequence of the MV H protein (VCR-H, 5 x 105 
IU particles/footpad) in saline with lactose or the formalin-inactivated measles vaccine 
(30 µl/footpad, FIMV, Pfizer, New York, New York)29, 39.  Control and vaccinated mice 
were sacrificed on days 0, 4, 7, 10, 14, 21, 28, 35 and 42.  Spleens, popliteal, superficial 
inguinal and axillary lymph nodes were removed.  CD4+, CD8+ and CD19+ cellular 
subsets were enriched using magnetic beads by following the manufacturer’s protocol 
(Miltenyi Biotec, Auburn, CA).  For some assays, CD4+ T cells or CD8+ T cells were 
depleted using magnetic beads.  On average, CD4+, CD8+ and CD19+ cells were 
isolated to 86.7 ±4.1%, 82.4±6.1% and 87.7±4.4% purity, respectively.  Blood was 
collected, allowed to clot for 30 minutes at room temperature and centrifuged at 16,000 x 
g for 30 minutes to obtain the serum.   
ELISA 
The protocol was followed as previously published except using a sheep anti-
mouse Ig HRP conjugated antibody for detection (Amersham, Piscataway, NJ)40.   
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ELISPOT 
The protocol has been previously described in more detail40.  Plates were coated 
with 5 µg/ml anti-interferon-γ (IFN-γ) or anti-interleukin-4 overnight (BD Pharmigen).  
The next day 1 x 105 cells were incubated with media containing DMSO, H peptide pool 
(20mers with 11aa overlap) at 5 µg/ml, MV lysate diluted 1:100, or 5 µg/ml of ConA for 
36 hours.  The plates were then washed and incubated with biotinylated rat anti-mouse 
IFN-γ or rat anti-mouse IL-4 antibodies at 2 µg/ml (BD Pharmigen). 
Microarrays 
Total RNA was isolated from cells using the RNeasy Kit (Qiagen, Valencia, CA) 
according to the manufacturer’s recommended protocol.  Quality assessment was 
determined by RNA Nano LabChip analysis on an Agilent Bioanalyzer 2100 (Agilent, 
Palo Alto, CA). 
Processing of templates for GeneChip Analysis was in accordance with methods 
described in the Affymetrix GeneChip Expression Analysis Technical Manual, revision 
five, utilizing reagents from the GeneChip Expression 3’ Amplification One-Cycle 
Target labeling kit (Affymetrix, Santa Clara, CA). For each sample, double stranded 
cDNA was synthesized from 1 µg of total RNA. Following column purification, an in 
vitro transcription reaction was performed.   This reaction incorporated biotinylated 
ribonucleotides to produce labeled antisense cRNA targets for hybridization.  Purification 
of biotinylated cRNAs was performed with the GeneChip Sample Cleanup Module 
(Affymetrix).  Fifteen micrograms of cRNA was fragmented by metal-induced hydrolysis 
in fragmentation buffer (250mM Tris acetate pH 8.1, 150 mM MgOAc, 500mM KOAc) 
at 94o C for 35 minutes.  Hybridization cocktails were prepared as recommended for 
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arrays of “Standard” format including incubation at 94oC for 5 minutes and 45oC for 5 
minutes, and centrifugation at maximum speed for 5 minutes prior to pipetting into the 
GeneChips (Affymetrix Mouse Genome 430 2.0). Hybridization was performed at 45oC 
for 16 hours at 60 rpm in the Affymetrix rotisserie hybridization oven.  The signal 
amplification protocol for washing and staining of eukaryotic targets was performed in an 
automated fluidics station (Affymetrix FS450) as described in the Affymetrix Technical 
Manual, Revision Five.  The arrays were then transferred to the GCS3000 laser scanner 
and scanned at an emission wavelength of 570 nm at 2.5 mm resolution (Affymetrix).  
Intensity of hybridization for each probe pair was computed by GCOS 1.2 software 
(Affymetrix). 
The CEL file images were viewed and affyPLM was used to determine outliers in 
quality control.  Data was normalized using R and Robust Multi-Array Analysis (RMA) 
v1.5.8 and significance was determined using Significance Analysis of Microarrays 
(SAM) v2.2141, 42, 43.  Day 0 controls and saline controls at each timepoint were combined 
if there were no significantly regulated genes found between the samples.  Pairwise 
comparisons were then made between the control and vaccine samples at each timepoint.  
Significant gene lists were annotated using Onto-Express44.   
 
Results 
Serum Antibodies and ELISPOTs 
Serum antibody levels were measured against whole MV lysate.  FIMV induced a 
more rapid response than VCR-H, but final titers were similar between the two vaccines, 
while saline alone did not induce antibody production (Figure 4.1).  Titers were still 
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increasing at day 42.  The quality of this antibody is not the same between the vaccines 
though, as the FIMV induces an antibody with lower avidity (J. Bergen, unpublished 
data).   
Spleen and lymph node cells IFN-γ production was rapidly induced to the H 
peptides and whole MV lysate by VCR-H, with the peak occurring at day 7 post-
vaccination.  The MV-specific cell number was maintained in the spleen through day 42 
while it slowly declined in the lymph node (Figure 4.2bc-4.3bc).  Many more cells 
responded to the H peptides than to whole MV lysate, which may reflect the dose of 
antigen that was used or the need for antigen processing.  The FIMV did induce some 
IFN-γ producing cells, but to a lower magnitude and it was transient.  There was a low 
level of non-specific IFN-γ production in mice that received the VCR-H (Figures 4.2a 
and 4.3a).  IL-4 production was not different between the two vaccine groups and saline 
controls (Supplemental Figures 4.1-4.2).   
To determine which cells were producing the IFN-γ, CD4+ T cells or CD8+ T 
cells were depleted using magnetic beads.  In general, depletion of CD4+ T cells 
decreased the response, while depletion of CD8+ T cells increased the response against 
the H peptide (Figure 4.4a).  However, neither eliminated the response, suggesting that 
both cell types contributed to IFN-γ production.  It is also possible that another cell type 
contributes to IFN-γ secretion.  The IFN-γ response to stimulation with whole virus lysate 
was primarily due to CD4+ T cells because CD4 depletion significantly reduced the 
number of spots and CD8+ T cell depletion increased the number of spots (Figure 4.4b).   
Microarray Analysis 
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 To understand the molecular differences in response to the two vaccines, 
microarray analysis was conducted on enriched CD4+ T cell, CD8+ T cell and CD19+ B 
cell populations from the spleen on days 0, 4, 7 and 28 for CD8+ T cells and days 0 and 4 
for CD19+ B cells.  A summary of the complete results is shown in Table 4.1.  There 
were only 2 significantly regulated genes in the CD4+ T cell samples.  On day 4, FIMV 
significantly induced 206 genes in the CD19+ B cells group while VCR-H did not induce 
any genes in B cells.  VCR-H induced 388 genes and down regulated 561 genes in CD8+ 
T cells on day 4, but FIMV did not show any changes until day 28 when it induced 60 
genes and down regulated 142.  These significantly regulated genes were then grouped 
into gene ontology biological processes.  The complete tables of significantly regulated 
genes and the genes found in each significant group are shown in Supplemental Tables 
4.1-4.10. 
CD19+ B cells FIMV Day 4 
There were six groups significantly up regulated in these samples for B cells: 
regulation of transcription, DNA-dependent, transcription, nuclear mRNA splicing, via 
spliceosome, mRNA processing, protein amino acid phosphorylation and cell cycle 
(Table 4.2).  The first four groups are all involved in transcription.  The genes found in 
these groups are predominantly transcription factors including foxp1, early B cell factor 1 
and transacting transcription factors 1 and 3.  The fifth group, protein amino acid 
phosphorylation, was composed entirely of kinases.  The final group, cell cycle, had a 
mixture of genes.  The only significant cellular component was the nucleus with 45 genes 
significantly regulated. 
CD8+ T cells VCR-H Day 4  
 83 
There were 388 up regulated and 561 down regulated genes induced by the VCR-
H vaccine in spleen CD8+ T cells at day 4 (Table 4.1).  By day 7 there was only 1 
significantly up regulated gene and none at day 28.  The up regulated genes at day 4 did 
not fall into any significantly regulated gene groups. 
 There were a large number of significantly down regulated groups of genes (Table 
4.3).  The top groups were involved in transcription and amino acid phosphorylation.  
The transcription-related groups included a number of splicing factors, STAT1, STAT3, 
STAT5a, transcription and binding factors.  The amino acid phosphorylation group was 
mainly composed of kinases.  After transcription and phosphorylation, the next groups 
were regulation of translation, Wnt receptor signaling pathway, cell cycle, intracellular 
signaling cascade, RNA processing, etc.  Many of the genes in these groups overlap with 
the transcription and phosphorylation groups. 
 Groups with unique genes included the cell surface receptor linked signal 
transduction group where there were three cytokine receptors that were down regulated: 
IL-4R, IL-6R and IL-17R. The protein amino acid dephosphorylation group was mostly 
phosphatases.   
 The significantly regulated cellular compartments included the nucleus, 
cytoplasm, spliceosome complex, intracellular, cytosol and ribonucleoprotein complex, 
which supports the finding that transcription is down regulated at this timepoint (Table 
4.4). 
CD8+ T cells FIMV Day 28 
 The only up regulated group of genes in day 28 CD8+ T cells from the spleens of 
FIMV vaccinated mice was development (Table 4.5).  It included sonic hedgehog and 
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two snail homolog genes (Supplemental Table 4.9).  Interestingly, the extracellular space 
was a significantly up regulated cellular component, although the genes were not 
generally immune related genes, except for one member of the complement component 
cascade. 
The main gene groups identified for the down regulated genes were involved in 
transcription and included Sp1 and STAT3.  About 50% of the genes down regulated in 
this group were also down regulated on day 4 following VCR-H vaccination.  The only 
significantly down regulated cellular component was the nucleus. 
 
Discussion 
In this study, we compared the VCR-H vaccine to the FIMV developed in the 
1960’s.  Both vaccines induced a similar antibody titer against whole MV lysate, 
although antibodies induced by the FIMV were of lower avidity (J. Bergen, unpublished 
data).  There was a profound difference in the induction of IFN-γ producing cells.  The 
VCR-H vaccine induced a robust response, while the FIMV induced a weaker, more 
transient response in both the spleen and the lymph node.  Depletion studies showed that 
the VCR-H IFN-γ response to the whole virus antigen was predominantly from CD4+ T 
cells, but the response to H peptides was both CD4+ and CD8+ T cells or potentially 
other cell types.   
Microarray analysis was used to compare the molecular changes in CD19+ B 
cells, CD4+ T cells and CD8+ T cells following vaccination.  There were only 2 
significantly regulated genes in the CD4+ T cell sample, possibly due to insufficient 
enrichment of antigen-specific CD4+ T cells.  On day 4 post-vaccination, CD19+ B cells 
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from mice inoculated with FIMV up regulated 206 genes involved in transcription, 
phosphorylation and the cell cycle.  Many of the up regulated genes, such as early B cell 
factor (EBF), special AT-rich sequence binding protein-1 (SATB1), BTB and CNC 
homology 2 (Bach2), Creb binding protein (CBP), Sp1, Sp3 and forkhead box P1 
(Foxp1) have been characterized in B cells. 
EBF is specific for B cells and is required for immunoglobulin expression and 
control of differentiation45, 46, 47.  SATB1, which can act as either a repressor or activator, 
is a docking site for chromatin-remodeling enzymes and is known to be involved in B 
cell tolerance48, 49, 50.  The B cell-specific, transcriptional repressor Bach2 is critical for 
class switch recombination and somatic hypermutation51, 52, 53.  It is expressed in 
proliferating germinal center B cells, but is shut-down as B cells differentiate into plasma 
cells54.  MHC class II gene transcription is increased by CBP and, when overexpressed, 
CBP strongly stimulates cell proliferation55, 56.  CBP is known to interact with EBF, HIF-
1α and Sp3.  Also, Sp1 regulatory elements are found upstream of the transcription start 
site56, 57.  HIF-1α is involved in the maturation of B cells and Foxp1 is expressed in 
germinal center B cells58, 59.  Sp1 and Sp3 are general transcriptional activators that often 
compete for the same binding sites60.  Overall, these genes suggest an activated, 
proliferating germinal center B cell response.      
 There were 388 up regulated and 561 down regulated genes on day four post-
vaccination in the CD8+ T cells of VCR-H inoculated mice.  The up regulated genes did 
not fall into any significantly up regulated groups, possibly because many have not been 
well-characterized.  The down regulated genes were largely involved in transcription and 
phosphorylation.  There are some well-studied genes including B cell 
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leukemia/lymphoma 11B (Bcl11b), GATA binding protein 3 (GATA-3), lymphoid 
enhancer binding protein (LEF1), Sin3a and signal transducers and activators of 
transcription 1, 3, and 5a (Stat) genes.  Bcl11b is a key regulator of T cell differentiation 
and survival61.  GATA3 binds to TCRα gene enhancer and is required for the expression 
of TCR α, β and δ and CD8α62, 63.  Forced GATA-3 expression inhibits CD8 
maturation64.  Wnt signaling includes LEF1, which is down regulated following antigen 
encounter65, 66.  Sin3a functions as a platform for histone deacetylase enzymes and other 
chromatin-modifying enzymes67.  T cell numbers and proliferative potential are reduced 
in Sin3a knockout mice67.  T cell subset expansion depends on low Stat1 levels and 
hence, proliferating, antigen-specific T cells have low Stat1 expression68.  Stat5 is 
required for T cell homeostasis and knockout animals have fewer CD8 T cells69, 70.  
Activation of both Stat3 and Stat5 promotes proliferation and survival, so the down 
regulation may mean a decreasing cell population71.  This gene expression signature 
suggests a dynamic CD8+ T cell population that is probably maturing and expanding, but 
also experiencing increased cell death. 
The FIMV did not induce significant changes in CD8+ T cells until 28 days post-
vaccination when 60 genes were up regulated and 142 were down regulated.  
Development was the only up regulated group while transcription was down regulated.  
The characterized, down regulated genes included Sp1, cellular nucleic acid binding 
protein 1 (CNBP) and nemo-like kinase (NLK).   Sp1 may regulate CNBP, which 
stimulates cell proliferation56.  NLK works to degrade LEF/TCF complex, which 
suppresses Wnt signaling72, 73.  There was significant overlap between the VCR-H day 4 
results and the FIMV day 28 results, with about 50% of the day 28 genes also down 
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regulated on day 4.  The reason for the delayed changes in CD8+ T cells following FIMV 
vaccination is unclear, but the overlapping gene expression profiles show a degree of 
similarity in the CD8+ T cell immune response.  Further research is needed to understand 
the extent of the overlap and the functional consequences of the differences between the 
expression profiles. 
The stark contrast between the immune responses to the VEE and FIMV vaccines 
provides an excellent system to study the necessary components for effective vaccination.  
Microarray analysis also provides a powerful method to analyze the molecular 
differences induced by the two vaccines in immune cell subsets of the mouse.  By further 
exploring this system and the contrasting immune responses, scientists can learn 
important principles to guide rationale vaccine design. 
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Table 4.1.  Microarray analysis results for spleen CD4+ T cells, CD8+ T cells and 
CD19+ B cells. 
  Day 4 Day 7 Day 28 
Saline 0 0 0 
VCR-H 0 0 0 
 
CD4+ T cells 
FIMV 0 2 up 0 
Saline 0 0 0 
VCR-H 388 up 
561 down 
1 up 0 
 
 
CD8+ T cells 





CD19+ B cells 












Table 4.2.  Significantly up regulated biological processes in CD19+ B cells on 









6355 Regulation of transcription, DNA-dependent 28 2.32E-04 
6350 Transcription 21 0.001 
398 Nuclear mRNA splicing, via spliceosome 8 0.002 
6397 mRNA processing 8 0.004 
6468 Protein amino acid phosphorylation 9 0.016 






Table 4.3.  Significantly down regulated biological processes in CD8+ T cells on 









6397 mRNA processing 31 0 
6350 Transcription 65 1.69E-10 
6355 Regulation of transcription, DNA-dependent 80 1.85E-10 
398 Nuclear mRNA splicing, via spliceosome 24 1.26E-08 
6468 Protein amino acid phosphorylation 30 8.55E-06 
45944 
Positive regulation of transcription from RNA 
polymerase II promoter 11 6.62E-05 
6366 
Transcription from RNA polymerase II 
promoter 6 0.002 
6445 Regulation of translation 5 0.003 
16055 Wnt receptor signaling pathway 7 0.004 
7049 Cell cycle 15 0.004 
7242 Intracellular signaling cascade 18 0.004 
6396 RNA processing 5 0.005 
16481 Negative regulation of transcription 5 0.005 
6357 
Regulation of transcription from RNA 
polymerase II promoter 6 0.010 
6915 Apoptosis 12 0.012 
9887 Organogenesis 8 0.013 
7166 
Cell surface receptor linked signal 
transduction 5 0.014 
7283 Spermatogenesis 6 0.015 
6512 Ubiquitin cycle 13 0.016 
50875 Cellular physiological process 6 0.027 
6974 Response to DNA damage stimulus 7 0.032 
7264 Small GTPase mediated signal transduction 8 0.034 
6260 DNA replication 5 0.034 
6470 Protein amino acid dephosphorylation 6 0.035 
4 Biological process unknown 25 0.036 
6605 Protein targeting 6 0.043 





Table 4.4.  Significantly down regulated cellular components in CD8+ T cells on 
day 4 from mice inoculated with VCR-H. 
GO ID Cellular Component Input Total Corrected P-Value 
5634 Nucleus 163 1.93E-09 
5737 Cytoplasm 46 3.92E-06 
5681 Spliceosome complex 10 5.90E-05 
5622 Intracellular 25 0.019 
5829 Cytosol 11 0.021 





Table 4.5.  Significantly regulated biological processes in spleen CD8+ T cells 
from mice on day 28 after inoculation with FIMV. 






7275 Development 6 5.52E-04 
    
Down regulated 
398 Nuclear mRNA splicing, via spliceosome 12 3.34E-08 
6397 mRNA processing 13 3.52E-08 
6350 Transcription 12 0.011 
4 Biological process unknown 8 0.022 



















Figure 4.1 Serum antibody titers against whole measles virus lysate.  BALB/c 
mice were inoculated with saline, VCR-H or FIMV vaccines on day 0 and serum 





























































































Figure 4.2 IFN-γ secreting cells in the spleens of vaccinated mice.  BALB/c
mice were inoculated with saline, VCR-H or FIMV vaccines and spleens were
removed on the indicated days.  Isolated splenocytes were stimulated with (a)
dimethyl sulfoxide (DMSO), (b) MV H peptide, (c) whole MV lysate or (d)






























































































Figure 4.3 IFN-γ secreting cells in the lymph nodes of vaccinated mice.
BALB/c mice were inoculated with saline, VCR-H or FIMV vaccines and lymph
nodes were removed on the indicated days.  Isolated lymph nodes were 
stimulated with (a) dimethyl sulfoxide (DMSO), (b) MV H peptide, (c) whole MV


















































Figure 4.4 IFN-γ secreting cells in the spleens of vaccinated mice depleted of 
CD4+ or CD8+ T cells.  BALB/c mice were inoculated with saline, VCR-H or
FIMV vaccines and spleens were removed on the indicated days.  CD4+ or
CD8+ cells were removed by magnetic bead separation.  Enriched cells were
stimulated with (a) MV H peptide or (b) whole MV lysate for 36 hours and IFN-γ




 By integrating biology, statistics and computation, microarray analysis has 
emerged as one of the most powerful technologies in biological research.  To harness the 
power of this technology, we developed an in vitro infection model where dendritic cells 
were experimentally infected and analyzed over the course of 24 hours.  These results 
were compared to other pathogen-host cell infection models to understand the cellular 
response to pathogens.  This approach identified PKR as a unique gene in MV infection, 
where it was not induced, while the other pathogens did induce this gene.  The interferons 
also showed an interesting pattern as all of the IFN-α genes were induced in measles, but 
only a few were induced in influenza, the only other virus that was compared.  None of 
the other pathogens induced IFN-α genes.  The metallothioneins were a novel group of 
genes that were widely induced by all pathogens in the DC-infection systems.  HIV 
infection of PBMCs and HCMV infection of fibroblasts did not induce any 
metallothioneins.  This in vitro infection model showed that microarrays could provide 
novel insights into pathogen-host cell relationships and that results could be compared 
between laboratories. 
 Next, we examined acute disease in Zambian children admitted to the hospital for 
measles infection.  There were several genes found to be up regulated at discharge and 
follow up including chemokines, such as CXCL2, CCL4 and IL-8, and the cytokines IL-
1β and TNF-α.  The down regulated genes were mainly involved in transcription and 
signal transduction.  There are difficulties interpreting the results from the human 
samples, because the cell composition of the PBMC compartment was changing over 
time.  The largest changes in cellular composition were at entry and there were no 
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significantly regulated genes at that timepoint, suggesting the results reflect gene 
expression changes. 
 Finally, two vaccines were compared in mice.  Following vaccination with either 
saline, VCR-H or FIMV, CD4+ T cells, CD8+ T cells and B cells were isolated at several 
timepoints.  The antibody titer was similar between the two vaccines, although other 
unpublished work in the lab has shown that FIMV induces a lower avidity antibody.  The 
cellular immune responses were very different as VCR-H induced a robust IFN-γ 
response in both the spleen and lymph nodes while FIMV induced a weaker and more 
transient response.  Microarray analysis identified a number of up regulated transcription 
factors and genes involved in signal transduction in B cells on day 4 following FIMV 
vaccination.  The overall transcriptional response indicated an activated and proliferating 
germinal-center B cell population.  A number of transcription factors were down 
regulated on day 4 following VCR-H vaccination and much later, at day 28, for FIMV.  
There was approximately 50% overlap between these two sets of down regulated genes 
and it suggested a mixed response with significant cellular expansion and increased cell 
death. 
 These results show the applicability of microarray technology to a wide array of 
biological research.  The power to generate hypotheses will expand the influence of 
microarray technology throughout biology as the raw materials become cheaper and the 
analysis becomes more standardized.  Undoubtedly, the ability of microarrays to 
characterize a tissue or cell sample through the expression of thousands of genes will 
transform biological research and medical science, profoundly improving the human 
condition.
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